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ANNEXURE 
 
 
fhg;G 
 
 
fhg;G 
Mjpguh guj;jpDNl KjNy fhg;G 
mz;lgfp uz;lnkDk; flTs; fhg;G 
NrhjpnaD kP];tupapd; RlNu fhg;G 
R+l;rhjp R+l;rKl ndhspNa fhg;G 
ghjpkjp rilazpe;j gpuhNdfhg;G 
ghUyfpy; fPHj;jpngw;w khNyfhg;G 
ePjpnaDk; khy;Njtp epiwNafhg;G 
ePlhop tpehafNd fhg;GjhNd1 
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INTRODUCTION 
“jhNd AyFf;F jj;Jtdha; epw;Fe; 
jhNd AyFf;F ijaYkha; epw;Fe; 
jhNd AyFf;F rk;gtkha;  epw;Fe; 
jhNd AyFf;F jz;RluhFNk!”  
(jpUke;jpuk;1941;) 
rptNk cyfpDf;F vd;Wk; xU gbj;jha; epw;Fk; nka;nghUshFk;. rptNk 
cyfpay; elj;jw; nghUl;Lj; ijayhfpa jpUtUshfTk; epw;Fk;. rptNk cyfpd; 
xt;nthU mZf;fs; NjhWk; jhDkha; kpspHe;J mt;tZf;Fs;Ns ,d;gUsr; 
rk;gTkha; epw;Fk;2. 
The Siddha medical works were passed on from Lord Siva to his consort, 
goddess Umayal. She, in turn, confided it to Nandhi deva, Nandhi Deva taught this 
science to  Thirumoolar who taught to other Siddhars
3
.       
 
Siddha medicines are classified into two kinds: 
      1.Internal medicine 
      2.External medicine 
Among 32 Internal medicine chendhuram is one among them and its shelf life is 
for 75 years. 
Chendhuram is described as a Metallic substances or salts which is made into red 
coloured powder, by the process of either burning them or drying them or exposing to 
the sunlight or keeping them in specialised tubes by adding decoctions, liquid of victory 
(ceyaneer), acid etc.chendhuram prepared by burning, roasting, grinding, exposing to 
sunlight, puda chendhuram. Annabethi Chendhuram is one of the types of puda 
chendhuram.
4 
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In general toxicology studies are performed to see whether and how the drug 
causes injury in: 
 Single dose studies (acute toxicity) 
 Repeated dose studies (subacute, intermediate, and long-term toxicity) 
The majority of toxicity tests are firmly based on studies in whole animals, 
because only in them is it possible to approach the complexity of organisation of body 
systems in humans, to explore any consequences of variable absorption , metabolism and 
excretion, and to reveal not only direct toxic effects but also those of a secondary or 
indirect nature due to induced abnormalities in integrative mechanisms or distant effects 
of a toxic metabolite produced in one organ that acts on another. 
All chemicals or drugs can cause harm at some levels of exposure. Toxicologists 
are responsible for determining the range of exposure that is safe and the levels of 
exposure that may be harmful to human health. Toxicity study is needed to identify the 
crossover points between no impact, beneficial effects and harmful effects. 
The efficacy of many preparations have been established but their safety is not 
the Siddha physicians should embrace ourselves the Siddha drugs are indeed safe and we 
should do this by using well established, modern and scientific methods such as 
pharmacological, biochemical, toxicological, and microbiological analysis according to 
the standard prepared by World health organisation. 
Anaemia is the most common disorders in Indian population, especially in 
women and children. According to WHO (2007) the maternal mortality rate (MMR) in 
India was 540. The prevalence of Anaemia amongst pregnant women in India is 87.6%. 
Anaemia is a decrease in the total amount of red blood cells (RBC) or haemoglobin in 
the blood. The main cause of Anaemia is lack of nutrition and frequent use of drugs to 
treat diseses. Despite the obvious effectiveness and efficacy of Iron supplementation, the 
main limitation is the lack of compliance. Especially when long term daily 
INTRODUCTION 
 
3 
 
administration is required, Gastro intestinal side effects associated with oral iron therapy 
included nauses, constipation, anorexia, vomiting, heartburn, diarrhoea etc. 
In Siddha system, Annabethi chendhuram is prescribed as best medicine for 
Anaemia(pandu). It also cures often associated symptoms like fever (suram), dysentery 
(seetha bethi) 
5
. The common procedure of detoxification, incineration, trituration, and 
verification. Even though this drug, is commonly used for long time, till date no chronic 
toxicity studies have been done to reveal its safety and efficacy. Toxicological screening 
is very important for the extension of the therapeutic potential of Annabethi chendhuram. 
So i have chosen this drug as my dissertation topic. 
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2. AIM AND OBJECTIVES 
AIM 
          To evaluate the safety profile ( Acute and long-term toxicity study ) of 
ANNABETHI CHENDHURAM on Wistar albino rats. 
OBJECTIVES 
 To analyse the physicochemical properties of Annabethi chendhuram 
 To evaluate Chemical and Spectroscopic analysis of Annabethi chendhuram 
 To find out Acute toxicity study of Annabethi Chendhuram as per WHO 
guideline. 
 To evaluate  Long term toxicity study of  Annabethi Chendhuram as per 
WHO guideline. 
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3.LITERATURE REVIEW 
md;dNgjp: 
md;dNgjp 120 cgurq;fspy; xd;whFk;.  
,jid> 
“ey;ytNd itf;fpuhe;j kd;dNgjp 
     ew;rhj;jpu NgjpAld; khzpf; fe;jhd; 
      nrhy;yntd;wh Ygur Ehw;wpU jg;gh 
          njhl;lth;f;Fr; nrhd;dka khFe; jhNd.”5 
vd;gjdhy; mwpayhk; 
md;dNgjp Njhw;wk;: 
“Ntijahd md;dnkd;w NgjpjhDk; 
       Tpsq;fpaNjhh; cw;gj;jp nrhy;yf; NfS 
khijahd kiyapDl UJT nghq;fp 
                  khrw;w fpuzj;jhy; nghq;fp ePWk; 
ghijahd kiyr;rTL vs;W NgU 
   ghq;fhd Kd;Wtpj tz;zkhFk; 
fhijahd fhrPr nkd;Wk; NgU 
         fUg;GkQ;rs; nts;isepw khFq; fhNz.”6 
,r;ruf;F ,Uk;Gf; fk;gpAld; fe;jfj; jpuhtfk; Nrh;j;J 
nra;ag;gLfpwJ. ,it fl;bfshAk; gr;ir epwkhAk; ,Uf;Fk;. md;dNgjp 
vd;w fhrPrk; kiyapy; cw;gj;jpahfpw njd;Wk; fWg;G kQ;rs; nts;is 
Mfpa Kd;W tpjkhf cs;sJ vd;W Nghfh; Ehy; $WfpwJ. ,J ePhpy; 
fiuAk; rhuhaj;jpy; fiuahJ. ,jd;Nky; fhw;Wg;gl;lhy; ntz;ikahd 
Jhsha;tpLk; 
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md;dNgjp NtWngah;: 
“md;dNgjpia miuiaf; NfS 
Mjpf;fy; ehjkhk; md;df;fhyd; 
fd;dkhk; Ngjpahq;fy; rTLehjq; 
fzkhd fspk;Gjhd; fy;Y Ntfq; 
rpd;dkhk; Ngjpahkiy tPhpakhFk; 
jpuhtfj;Jf; fLq;fhhp NgjpahFk; 
kt;tdkhk; Ngjpah kiyUJTkhF 
khrw;w td;dnkd;w NgjpjhNd”7 
 fy;ehjk; 
 md;dfhyd; 
 fy;ruL ehjk; 
 fspk;G 
 fy;Ntfk; 
 fLq;fhuNgjp 
 kiyUJ8 
Rit: 
Jth;g;G Rit  
tPhpak;: 
ntg;g tPhpak; 
nra;if:  
mfr;nra;if: 
md;dNgjpf;F 
 cly; cuKz;lhf;fp 
 Jtu;g;gp 
 UJ cz;lhf;fp 
 ehw;wkfw;wp 
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 GOf;nfhy;yp 
 Kiw ntg;gfw;wp 
Gwr;nra;if: 
Jth;g;gp 
ntg;gKz;lhf;fp 
tiffs;: 
  kQ;rs; 
  fWg;G 
  ntz;ik 
gQ;rGj $W: thAtpd; $W 
nghJFzk;: 
 Kiytpuzk; #iyke;j Kl;lhikf; fl;b 
 tpisAwd;k NfhjuNeha; tPl;Lk;- tiskiyNghw; 
 fhl;Lkd;de; jd;idf; fzj;jpw; rykhf;fpf; 
 fhl;Lkd;d NgjpaJ fhz; 
nghUs;: 
 md;dj;ij ePuha;fiuf;fpd;w md;dNgjp 
 Kiytpuzk;  
 #iy 
 m[Puzk; 
 gha;fpd;w Mikf;fl;b 
 kNfhjuk; ,itfis ePf;Fk; vd;gu; 
kw;Wk; ,jid 
 #jfg; ghz;L 
 #jf;fl;L 
 fUg;gg;gpuNkfk; 
 fha;r;ry; fl;b 
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 Kiwr;Ruk; 
 vOQhapW 
 ehl;gl;l ff;fpUky; 
 jl;ilfpUkp Nuhfk; 
 ghz;L 
 mf;fp 
 Nkf tpuzk; 
 rPo;%yk; 
 Mrdtha; ntspg;gly; 
 fUg;gtpuzk; 
Kjypa gpzpfSf;F NkYf;Fk; cgNahfpf;fyhk;. ,jpy; mak; 
,Ug;gjpdhy; ,Uk;gpdhy;jPUk; gpzpfs; ePq;Fnkd;W fz;Lnfhs;s Ntz;Lk; 
 md;dNgjpahdJ Gspg;ghAk; fz;fSf;F ed;ik 
nra;Ak;gbahdjhAk; Nuhkq;fisehrk; gz;Zk;gbahdjhAk; tp\Njh\k; 
thjNjh\k; rpNyj;kNjhlk; ,uzNjh\q;fis Nghf;fbf;Fk;.5 
Rj;jp Kiwfs;: 
 Njitahd md;dNgjpia ePupy; fiuj;J rpwpjsT fe;jfj; 
jpuhtfk; tpl;L tbfl;b cg;G ciwAk; gf;Ftj;jpy; fha;r;rpf; nfhs;tNj 
Rj;jpahFk;.5 
 md;dNgjpia fupryhq;fz;zp ,urj;jpy; Ntfitj;jhy; Rj;jpahFk; 
 gor;rhw;wpy; xUehs; KOtJk; Cwitj;J jz;zPu; tw;Wfpw 
tiuapYk; itj;jhy; Rj;jpahFk;.9 
 md;dNgjpia rptf;f tWj;J vLf;fTk;.10 
md;dNgjpia cgNahfpf;Fk;NghJ ftdpf;f Ntz;Lgit: 
1. md;dNgjpia mUe;jptUk; fhyj;J kyk; fWj;Jf; nfl;l 
ehw;wj;NjhL ,Uf;Fk; 
2. md;dNgjpia rhg;gpLk;nghOJ tplhKaw;rpaha; 
thuj;jpw;nfhUKiw tpl;L tpl;L rhg;gpl Ntz;Lk; 
3. md;dNgjpia Muk;gj;jpy; rhg;gpLk; nghOJ mjpf mstpy; 
nfhLf;f $lhJ. mjpfk; nfhLj;jhy; kyk; fWj;J kyge;jk; 
cz;lhFk; 
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4. md;dNgjpia mUe;jpf;nfhz;L tUk;nghOJ 
gj;Jehisf;nfhUKiw Ngjpf;Ff; nfhLj;jhy; ey;y 
FzKz;lhFk; 
5. md;dNgjpia rhg;gpLk;nghOJ Gspg;igAk; Gspg;Gs;s 
goq;fisAk; Kw;wpYk; ePf;fp maj;jpw;F $wpa gj;jpak; 
fhj;jy; Ntz;Lk;. 
6. Foe;ijfSf;F md;dNgjpia nfhLf;f Ntz;ba 
mtrpakpUe;jhy; Fiwe;j mstpy; nfhLf;fTk;. 
7. md;dNgjpia cztpw;F gpwNf mUe;j Ntz;Lk;. 
Gpw cgNahfk;: 
 md;dNgjpiaf; fy;tj;jpypl;L Ntz;ba msT ePh;tpl;L 
Fok;G gf;Ftj;jpy; miuj;J Mrdk; ntspj;js;sy;. fUg;ig 
tpuzk;. ngz;fspd; cWg;Gj;js;sy; Kjypatw;wpw;F NkYf;F 
Nghlr; RUf;fkile;J cs;Sf;F ,Oj;Jf;nfhs;Sk;. 
 KyNuhfj;jpy; fhZk; ,uj;j xOf;fpw;F md;dNgjpj; Jhs; 
xU tuhfndilia Rkhh; ,uz;L Nrh; ePhpy; fiuj;J 
xt;nthUehSk; t];jp nra;J te;jhy; ,uj;jk; epw;Fk;. 
 rpj;j itj;jpaj;jpah;fs; md;dNgjpiaj; jdpahf cs;Sf;F 
nfhLg;gjpy;iy ,jid jdpahfthtJ my;yJ 
kw;wruf;FfSld; $l;bahtJ nre;Juhkhf;fpf; 
ifahSfpd;wdh; 
 md;dNgjpia ,uz;L cSe;njilia xu; mTd;]; 
epyNtk;GFbePhpy; fye;J ehs; xd;Wf;F Kd;W Ntis tPjk; 
gyf;FiwT ghz;L Kjypa Neha;fSf;F nfhLf;f jPUk;. 
 md;dNgjpj;;Jhs; 30 cSe;njil fhpaNghsj;Jhs; 12 
cSe;njil Nrh;j;J NghJkhd msT Njd;  $l;b miuj;J 
khj;jpiufs; nra;J ehs; xd;Wf;F Kk;Kiw nfhLj;Jtu 
ghz;LTld; $ba nts;is #jf xOf;F ePq;Fk; 
 kNfhjuk; Nrhig gyf;FiwT Kjypa Neha;fspy; md;dNgjp 
1 cSe;njilia ,uz;L Nrh; ePupy; fye;J mUe;jp te;jhy; 
ew;gyid mspf;Fk; 
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NrUk; kUe;Jfs;: 
md;dNgjp nre;Jhuk;: 
 Rj;jp nra;j md;dNgjpia fhb ePupyiuj;J tpy;iy nra;J ,uz;L 
my;yJ %d;WGl kpl nre;JhukhFk; 
msT: miu Kjy; xU Fd;wp((65-130 kp.fp) 
mDghdk;: Njd; 
jPUk;Neha;fs;: rPjNgjp ghz;L 
ntb md;dNgjp nre;Jhuk;: 
 Rj;jp nra;j md;dNgjp xU gq;F Rj;jp nra;j ntbAg;G fhy; gq;F 
,t;tpuz;ilAk; vYkpr;rk; gor;rhW tpl;Lg; Gul;b ,uz;L my;yJ Kd;W Glkpl 
nre;JhukhFk; 
msT: miu Kjy; xU Fd;wp (65-130 kp.fp) 
mDghdk;: Njd; 
jPUk;Neha;fs: ghz;L Nrhif ngUtapW fhkhiy. 
Ngjp tPu nre;Jhuk;: 
 md;dNgjp 5 gyk; 
 tPuk; 1 gyk; 
 vYkpr;rk; gor;rhW – nrhy;yj;jf;f msT 
  Nkw;fz;l ,uz;L ruf;ifAk; fy;tj;jpw; nghbj;J 
vYkpr;rk;gor;rhw;iwr; rpWf rpWf thh;j;J ,uz;L rhk Neukiuj;J tpy;iy 
nra;Jyh;j;jp xl;bypl;L NkNyhL %b Ie;J rPiy kz; nra;Jyh;j;jp ftrj;jpd; 
MW gq;nfil tul;bapw; Glkpl;L Mwpd gpd;ndLj;J fy;tj;jpw; nghbj;J 
Kd;NghyNt vYkpr;rk;gor;rhw;iw thh;j;J miuj;J tpy;iy nra;J Kd;W 
GlkplTk; Kd;whk; jlitAk; ,t;tpjNk Glkpl;nlLf;f Nkyhd 
nre;JhukhapUf;Fk; tPukhdJ jd; rj;ij tpl;L xbNghFk; 
msT: 1 Kjy; 2 Fd;wp (130-260 kp.fp) 
mDghdk;: Njd; nea; 
jPUk;Neha;fs: thA rk;ge;jkhd Neha;fs.; Ruk;. rd;dp.. 
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md;d gto nre;Jhuk;: 
 md;dNgjp 5 gyk; 
 ehtw;gok; 1 gyk; 
 vYkpr;rk; gor;rhW – nrhy;yj;jf;f msT 
  Nkw;fz;l ,uz;L ruf;ifAk; fy;tj;jpw; nghbj;J 
vYkpr;rk;gor;rhw;iwr; rpWf rpWf thh;j;J ,uz;L rhk Neukiuj;Jk; tpy;iy 
nra;Jyh;j;jp xl;bypl;L NkNyhL Kb rPiy kz; nra;Jyh;j;jp ftrj;jpd; MW 
gq;nfil tul;bapw; Glkpl;L Mwpd gpd;ndLj;J fy;tj;jpw; nghbj;J Kd;NghyNt 
vYkpr;rk;gor;rhw;iw thh;j;J miuj;J tpy;iy nra;J %d;W GlkplTk; %d;whk; 
jlitAk; ,t;tpjNk Glkpl;nlLf;f Nkyhd nre;JhukhapUf;Fk;  
msT: 1 Kjy; 2 Fd;wp (130 - 260 kp.fp) 
mDghdk;: Njd; nea; 
jPUk;Neha;fs;: rak; ,iug;gpUky; ,uj;j fhrk; 
md;dNgjp jpuhtfk;: 
 jhkpuj;ij Jha;ikg;gLj;jTk; nre;Jhupf;fTk; gad;gLfpwJ.11 
jhk;gpu md;dNgjp nre;Jhuk;: 
msT: Jtuk; gUg;gsT 
mDghdk;: Njd; 
jPUk;Neha;fs;: Fsph;Ruk>; fgRuk; 
ehuazr;nre;Jhuk;: 
msT: Jtuk; gUg;gsT 
mDghdk;: jpg;gpypia neUg;gdypy; ntJg;gp ,bj;J vLj;j #uzk; 
jPUk; Neha;fs;:rh;thq;f thjk>; Njhs;thjk;12 
rpq;fp nre;Jhuk;: 
msT: 25 – 30 kpfp 
mDghdk;: Njd; 
jPUk; Neha;fs;:Nkfuzq;fs; thj gpj;j Neha;fs; FzkhFk; 
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rJh; Kf nre;Jhuk;: 
msT: 50- 100 kpfp 
mDghdk;: Njd; 
jPUk; Neha;fs;:fLikahd rPjNgjp> uj;j Ngjp13 
fe;jh;fhsfz;l Nkfehuaz nre;Jhuk;: 
msT: miu gzntil 
mDghdk;: Neha;f;F jFe;j mDghdk;14 
jPUk; Neha;fs;:Ru Nuhfk;> fgNuhfk;. 
fh]p] gw;gk;: 
msT: 200-500 kpfp 
mDghdk;: Njd; 
jPUk; Neha;fs;:fhzf;fb> ghz;L> fy;yPuy;> kz;zPuy; ngUj;jy; 
ehAUtpcg;G Fok;G: 
msT: 1 Fd;wpkzp (130 kp>fp) 
mDghdk;: jhk;gpu nre;Jhuk; 1 gzntil 
jPUk; Neha;fs;: vz;tif Fd;kk;> tha;T> 
rq;f jpuhtfk;: 
msT: 1 Jsp 
mDghdk;: ePh; 
jPUk; Neha;fs;:khh;G typ> tha;T. 
ntbAg;G jpuhtfk;: 
msT: 1 Jsp 
mDghdk;: ePh; 
jPUk; Neha;fs;: tha;T jPUk;15 
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fghpnkOF: 
gpzpahsd; epiyikf;F jf;fgb VNjDnkhU mDghdj;jpy; nfhLf;f Fsph;Ruk>; 
rd;dp> #jfthA Kjypahd jPUk;16 
ntbAg;;G nraePh; 
msT: 4-10 Jspfs; 
jPUk; Neha;fs;: 
ePh;mUfy;> ePh;vhpr;ry;> ePh;fl;L> rijailg;G> ePh;jhiuGz;> fy;yilg;G> gpuNkfk;.17 
JUR nre;Jhuk;: 
msT: 1-3 Fd;wp (130 -390 kp.fp) 
jPUk; Neha;fs;: 
KythA ngUq;fopr;ry;> ghz;L> Ruk;> rak;> ,Uky;> ,iug;gpUky;. 
tPu gw;gk;:18 
miu – xU mhprp vil. 
jPUk; Neha;fs;: vz;tif Fd;kk>; Kd;dprpT> gpd;dprpT> #iy> irj;jpak;> 
Njhlk;> fpue;jp> Fl;lNeha;fs;. 
NrUk; gpw kUe;Jfs;: 
nre;Jhu nraePh; 
Ngjpjpuhtfk; 
nrhh;zrhu jpuhtfk; 
tz;zjpuhtfk; 
rpyhrj;J nre;Jhuk; 
rq;f jpuhtfk17; 
MWKf gw;gk;19 
etNyhf nre;Jhu nraePh; 
nre;Jhu jpuhtfk;  
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FERROUS SULPHATE 
VERNACULAR NAMES: 
Sans:      Kasisa ,Hurt-tutia 
Eng:  Green vitriol,Green coppearas,Sulphates of iron,Crude ferrous           sulphate,Iron 
sulphate,Salt of Steel,Sulphate ferreux. 
Pers:       Zankurmandi 
Hindi:     Haratutuia, Kasis 
Guj:        Harakasis 
Tam,tel: Annabethi 
Kash:      Sang-i-sabz 
Tel:         Tagramu 
Malay:    Madhukalpa
20 
Iron sulphate, chemical compound, Feso4.  It is known as the monohydrate, 
FeSO4.H2O; the tetrahydrate, FeSO4.4H2O; the pentahydrate, FeSO4.5H2O; and the 
heptahydrate, FeSO4.7H2O. The heptahydrate is also called green vitriol, copperas, or 
melanterite (a mineral that commonly occurs with pyrite). 
It is a blue-green monoclinic crystalline water-soluble salt. It is prepared 
commercially by oxidation of pyrite (iron sulphide) or by treating iron with sulphuric 
acid. It is used in in the manufacture of inks, in wool dyeing as a mordant, and in water 
purification as a mordant,and in water purification as a substitute for aluminium 
sulphate. It melts at 64
o
C, AND at 90
o
C it loses water of hydration to form the 
monohydrate, a monoclinic, crystalline powder that occurs naturally as the mineral 
szomolnokite. The mineral siderotil is iron sulphate pentahydrate. 
PRODUCTION 
In the finishing of steel prior to plating or coating, the steel sheet or rod is passed 
through pickling baths of sulphuric acid.This treatment produces large quantities of iron 
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sulphate as a waste product.Iron sulphate is prepared commercially by oxidation of 
pyrite, by treating iron with sulfuric acid. 
ACTION: 
It is valuable 
 Tonic, 
 Astringent 
 Haematinic 
VARIETIES: 
It was divided into two varieties by the ancient Hindu chemists. 
1) Valuka kasisa or dhatu kasisa, the green variety (ferrous sulphate) 
2) Pushpa kasisa the yellowish variety which is probably iron sulphate covered 
with basic sulphate of sesquioxide from absorption of oxygen. 
“Coppers of commerce", is produced principally from the so called 
alum shales from which alum is prepared. As is the case also with alum, copperas is 
found sometimes as a natural exudation upon alum shales and other rocks which include 
“iron pyrites”. Crude greenish-blue crystals of sulphate of iron are available in all the 
bazaars in India. Its taste is very astringent or styptic and without any odour, acid 
reaction, soluble in water, insoluble in alcohol. 
HYDRATES:
21 
Iron sulphate can be found in various states of hydration, and several of these forms exist 
in nature. 
 FeSO4.H2O (mineral: szomolnokite) 
 FeSo4.4H2O 
 FeSo4.5H2O (mineral: siderotil) 
 FeSo4.7H2O (mineral: melanterite) 
At 90
0
C, the heptahydrate loses water to form the colourless monohydrate it also called 
green vitriol or copperas. 
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PHYSICAL AND CHEMICAL PROPERTIES:
22 
Colour – Brown / green crystalline solid 
Density -1.898g /cm
3
 
Melting point - 64
0
C 
Boiling point - 90
0
C (becomes FeSo4) 
FeSo4.7H2O - 90% 
Mgso4.7H2O - 4% 
pH >1 (10%) 
Other sulphates - 1% 
Insoluble - 0.1% 
Free acid - 0.3% 
Residual moisture - 5% 
Fe (active substance) - 18% 
Dissolves easily in water - 570g/l (20 deg C) 
It melts at 64
0
C, and at 90
0
C it loses water of hydration to form the monohydrate, 
a white, monoclinic, crystalline powder that occurs naturally as the mineral 
szomolnokite. The mineral siderotil is iron sulphate pentahydrate  Iron sulphate is the 
chemical compound with the formula (FeSO4). Also known as ferrous sulphate, or 
copperas, iron sulphate is most commonly encountered as the blue-green heptahydrate. 
In its anhydrous, crystalline state, its standard enthalpy of formation is  fH
O
solid = -
928.4Kj.mol
-1 
and its standard molor entropy is S
0
solid =107.5J.K
-1
.mol
-1
. 
PURIFICATION: 
The ferrous sulphate is dissolved in water. A small quantity of sulphuric acid is 
added to it filtered and heated until it attains the consistency of dry salt. 
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PROPERTIES: 
 This has got bitter, body strengthening and hypothermic properties. It also 
destroys the worms and improves the development of sexual functions. 
The following points are to be remembered while using the ferrous sulphate: 
1. When the ferrous sulphate is taken, the stool will be black in colour with bad 
smell. 
2. Ferrous sulphate should be taken continuously with a regular gap, once a 
week. 
3. If the ferrous sulphate is consumed in excess quantity, the stool will be 
blackened besides causing constipation.
  
 
USES:
23 
 Preparations made of it was generally bhasma, oil, and solution. Bhasma 
is prepared by taking equal quantity of iron sulphate and sulphur, 
reducing them fine powder, mixing and mixture or mass. To this is added 
tripala, pepper, honey, ghee and the whole is triturated.  
A Dose is ¼ to 2 grains a day with honey and milk. 
 The bhasma is alternative and diuretic and is given in enlargement of the 
liver. 
 Iron sulphate, on accounts of its astringent properties, is used as a lotion 
in erysipelas, anaemia and constitutional debility, following on malaria, 
kala-azar. 
Following remedies are valuable in Anaemia and debility: 
1. A grain of ferrous sulphate in an ounce each of omum water and 
infusion of chiretta thrice a day after food. This is useful in larger doses 
in case of neuralgic of rheumatic attacks recurring periodically among 
the week. 
2. 24 grains of ferrous sulphate and 30 grains of black pepper and 
cinnamon powder, made into 12 pills in sufficient quantity of honey and 
given in a dose of 1 pill twice a day. 
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3. For anaemic females suffering from cholera etc leucorrhoea and 
amenorrhoea purified aloes in equal quantity to ferrous sulphate may 
be advantageously added. 
4. Through iron is useful in simple anaemias, it is useful or even harmful in 
pernicious anaemia. 
5. It sticks or solution applied to foul ulcers various skin diseases as 
eczema, pruritis, intertrigo etc. 
6. It is also applied in fistula in ano for the burning and pain in piles with 
benefit. 
7. In bleeding piles and prolapse of rectum, daily enemas of the simple 
solution of sulphate are serviceable. 
8. In chronic disease, an ointment made of iron pyrites and ghee is used 
with benefit. It is apt to irritate the stomach. 
9. Ferrous sulphate is applied for the purification of water by flocculation 
and for phosphate removal in municipal and industrial sewage treatment 
plants to prevent eutrophication of surface water bodies. Large 
quantities of this salt are used as a reducing agent, mostly for the 
reduction of chromate in cement. 
10. Ferrous sulphate is also used to fortify various foods with iron,  for 
example, the enriched corn meal in Cheetos. 
11. Ferrous sulphate is an iron preparation. Iron is a vital component of 
haemoglobin (oxygen-carrying pigment of red blood cells ) and is 
therefore important in the formation of red blood cells. It is also a 
component of myoglobin, a pigment which stores oxygen in muscles for 
use during exercise.  
12. Iron is an essential component of several enzymes and is involved in the 
uptake of oxygen by the cells and the conversation of blood sugar to 
energy. 
13. Colouring: Ferrous sulphate is used in the manufacturing of inks, most 
notably iron gall ink, which was used from the middle ages until\the 
American Resolution.          It also finds use in wool dyeing as a 
mordant. Ferrous sulphate can also be used to stain Concrete a yellowish 
rust colour. 
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NOT TO BE USED IN:
24 
 Decreased numbers of red blood cells in the bloodstream caused by an 
increase in their breakdown  ( haemolytic anaemia ). 
 Iron storage disorder ( Haemosiderosis,), Hemochromatosis. 
 Known sensitivity or allergy to any ingredient. 
USED WITH CAUTION IN: 
 Inflammatory bowel disease such as ulcerative colitis or Crohn's disease. 
 Narrowing of a gut. 
SIDE EFFECTS:
25 
         Medicines and their possible side effects can affect individual people in 
different ways. The following are some of the side effects that are known to be 
associated with this medicine. Because a side effect is stated here, it does not mean that 
all people using this medicine will experience that or any side effect. 
 Abdominal pain 
 Constipation 
 Diarrhoea 
 Nausea and vomiting 
The side effects listed above may not include all of the side effects reported by the 
drug‟s manufacturer. Side effects of therapy may include nausea and epigastric 
abdominal discomfort after taking iron. These side effects may be minimized by taking 
ferrous sulphate at bedtime. Copperas was given indiscriminately by untrained persons 
to slaves in the 18
th
 and 19
th
 centuries for various ailments. The knowledge that it would 
cause violent nausea and vomiting made it an ideal "remedy" for virtually anything that 
ailed a slave and kept him from work. Many slaves were poisoned and died from this 
practice.  
1. When taken together with antacids, the absorption of iron may be 
reduced.  
2. When taken together with tetracycline antibiotics, the absorption of both 
medicines may be reduced. 
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3. The absorption of the following medicines may be reduced when taken 
together with  
   Iron  
 Penicillamine 
 Zinc salts 
Recent Researches about Annabethi: 
Comparative study of khasisabhasma and ABC with reference to their 
pharmaceutical study:
26 
The ancient texts of Rasa Shastra classified the minerals as Maharasa, Uparasa, and 
SadharanaRasa on basis of their importance in mercurial processing. „Kasisa‟ is 
described under Uparasa group by Rasacharyas. It is one among the Iron containing 
minerals. While reviewing the Modern literature, we find medicinal use of Iron after 
17th century by the discovery of food rich Iron. „Kasisa‟ is an iron compound which is 
presented in this article in two forms i.e Kasisa bhasma and Annabhedi chenduram. 
Annabhedi chenduram is siddha medicine. Like Ayurveda, Siddha is also a traditional 
medical system of India.. Many research programmes were conducted on Kasisa Bhasma 
of Ayurveda and Annabhedi Chendooram of Siddha medicine for the management of 
Anaemia. So far no comparative study is taken up to identify the supremacy between the 
two. So comparative study with respect to pharmaceutical view studied in this article. 
Kasisa Bhasma and Annabhedi Chendooram contain number of similarities both in terms 
of composition and preparation with minimum variations. 
A Clinical Study on Annabedi Chenduram in Pandu Based on Siddha Concept:
27 
The specific preparation used in this study is reported contain 25% ferrous iron which 
given good response of average 30% raise  Hb% during treatment. There is a definite 
qualitative improvement in the symptomatic amelioration of  anaemic condion. 
Pharmaceutico-therapeutic vistas of Kasisa (green vitriol) in Ayurveda: 
Since ages the Indians have the knowledge of using Kasisa (hydrous ferrous sulphate/ 
green vitriol) in different modalities. Kasisa is commonly placed under Uparasa group of 
drugs and is widely used in therapeutics of Ayurveda. Brihatrayi (Charaka Samhita, 
Sushruta Samhita and Ashtanga Hridaya) is the first known Ayurveda literature that 
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introduced its medicinal utilities, and later on Rasashastra (the iatrochemistry of 
Ayurveda) treatises comprehensively described its complete mineralogical profile, 
sources, distribution, varieties, Shodhana (purification and detoxification), Marana 
(calcinations cycles), Satvapatana (metal extraction), pharmacodynamic properties, 
actions, therapeutic indications, posology, adjuvants, and formulations in a systemic 
manner. Scattered information exploring therapeutic potential of Kasisa is accessible and 
there is need to assemble it. Therefore, an effort is made to assemble the scattered 
information in prehistoric texts, Brihatrayi, Nighantu, Rasashastra and other Ayurvedic 
treatises along with modern evidences highlighting the role of Kasisa in therapeutics.
28 
Scientific basis for the preparation and charecterization of iron based traditional 
drug annabethi chendhuram: A Meterialistic approach:
 
Iron based traditional Ayurvedic drug Annabethi chendhuram is used 
therapeutically for the treatment of disease like Anaemia, Leucoderma, Prolapse of 
uterus and rectum, Spleenic disorders. The structural and textural properties of the 
starting materials and the prepared drug were charecterised systematically by different 
charecterisation techniques like PXRD, Zeta Potential Analysis, Particle analysis, 
FTIR,SEM, and BET surface area analysis. The results obtained by charecterization of 
the samples clearly explain the formation of Fe
2
O
3
 ,reduction in particle size, 
modification of surface energy and formation of metal complex with organic moieties. 
The strict post and pre preparation conditions followed play an important role in the 
morphology and medicinal activity of the drug Annabethi chendhuram.
29
 
Toxicological evalution of Kasisa bhasma(Green vitriol), an ayurvethic organo 
metallic preparation: 
Repeated dose oral toxicity study for 28 days of  Kasisa bhasma(Feso4, 7 H2 O, 
Green vitriol), a popular ayurvethic formulation, was carried ouy in Wister rats to 
evaluate the toxicity, if any. In this study, the dose schedule was 225,112.5 and 22.5 
mg/kg/day, for 28 days resulted in nomortality. In female rats showed significant 
decrease of SGPT level, Eosinophil count, and prothrombine time respectively, whereas 
males  showed significant decrease of total protein. Moreover there was no changes 
observed in histopathological evaluation of the high dose group animals when compared 
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to control group, which revealed that there was no adverse effect of Kasisa bhasma, the 
classical Ayurvedic Organo-metallic preparation in oral consumption in Wistar albino 
Rats for 28consecutive days for study
30
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vYkpr;ir 
NtWngah;fs; 
 nrg;gpdNjhh; NjrpePh; $jdr;rhunkd;Wk; 
  rpWfpspapd; gor;rhW ntd;Wk; NgU 
 neg;gpd Njhh;epk;gdtr; rhnud;Wk; NgU 
  Nzhthsp khjurp nad;Wk; NgU 
 Ag;gpdNjhh; cgNzuQ; rfnkd;Wk; NgU 
  Aly;gpj;j Kwpahj nud;Wk; NgU 
 tpg;gpngWk; NgRq;fdpkhj nud;Wk; NgU 
  Nrayhd ntYkgpr; rk;goj;jpd; NgNu 
 rk;gPuk; 
 NjrpePh; 
 epk;gtdr;rhW 
 cly;gpj;jKwpkhjh; 
 NgRq;fdpkhjh; 
 rpWfpspapd; gor;rhW 
 Nehthsp khjurp 
 $jor;rhuk; 
 rk;gpNfr 
 nfhk;gpDl gok; 
 NrhgPrk; 
 Rk;gPNuhyj;jpuk;31 
Rit: 
 Gspg;G 
jd;ik: 
 ntg;gk; 
gphpT: 
 fhh;g;G 
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gad;gLk; cWg;G: 
 ,iy> fha;> gok;> gourk;> vz;nza;> 
nra;if: 
 Fsph;r;rpAz;lhf;fp 
Fzk;: 
 jPnjY kpr;rq;fha; Nlh;Kj;Njh lj;ijAKs; 
 thjfg #iyiaAk; khnfhba rhjpnaDQ; 
 rhj;jpUs; kj;ijAKs; jq;fkUe; jpl;lijAk; 
 gpj;jntg;ig Ae;jzpf;Fk; NgR.32 
,J Kf;Fw;wk;> #iy> the;jp> Fd;kk;> ,LkUe;J> moy; ,itfisg; Nghf;Fk; 
 Rjhgyhf; fdpfha rKyK KdNt 
 Epjhdkha;g; gapj;jpa epe;ijiah afYnk 
vYkpr;rk;gok; fha; ,itfis nfhs;spd; jPf;Fw;wj;jhy; cz;lhd Neha;fSk; 
ntwp NehAk; Nghk; 
 ke;jphpf;F ke;jphpaha; kd;dDf;F kd;dnddj; 
 je;jpf;F kpj;jpud;Nghw; rhUNk Ke;jtU 
 fk;gPu kha;r;ruf;fpd; nfz;zpakha; thflu;f;Fr; 
 rk;gPu khnkOkpr; ir. 
vYkpr;rk; gok; ke;jpup vdf;$Wk; jPf;Fw;wj;ijj; jzpf;Fk;. je;jphpahfpa 
Iaj;jpw;F md;gd; NghypUe;J mdy; jzpf;Fk; 
vYkpr;rk;goj;ij urKk; CWfhAkhff; fw;gKiwaha;g; gj;jpaj;JlNd 
MWkhjq;nfhs;s eiu> jpiu> khWk; gpbg;G> ngUtapW> gf;f#iy> %lk;> 
ntwp> kaf;fk;> kdr;Nrhh;T vd;gitfSk; mbNahL ePq;Fk; 
  Nfhzj; JisAq; FwpAisAq; nfhf;fhfpy; 
  Nfhzj; JisAq; FUisNghw; Nfhzr; 
  rlkjpAz; khwhkw; rz;33 
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vYkpr;rk; goj;jpd; gad;fs;:35 
 ,e;j gourj;ij Ntisf;F miu mTd;]; tPjk; jpdk; 
,uz;L Ntis 3 mTd;]; ePUld; rh;f;fiuapl;Lf; nfhLf;f 
Mahrk; jhfk;> mk;ikapdhy; Njh;e;j Njfntg;G mlq;Fk; 
 miu vYkpr;irrhw;wpy; rpwpJ ePh; tpl;Lf; fyf;fpf;nfhLf;f 
khh;G vhpr;ry; ePq;Fk; 
 ,r;rhWld; rkdsT ePh;tpl;Lf; fyf;fp tha; nfhg;gspj;Jtu 
tpuzq;fs; MWk; 
 ,jd; urj;Jld; rpwpJ cg;Gf; $l;br; rhg;gpl;L tu 
Ruf;fl;bfs; fiuAk; 
 Neh;thstpj;J> fhl;lhkzf;F gUg;G ,itfshy; msT 
fle;J Ngjpahdy; 2 mTd;]; vYkpr;rk;gor;rhw;iw fQ;rpapy; 
Nrh;j;Jf; nfhLf;f mjd; Ntfj;ij Kwpf;Fk; 
 ePh;f;fLg;G> ePh;vhpr;ry; vYkpr;rk;gor;rhW ey;nyz;nza; fye;J 
rhg;gplj; jPUk; 
 ntq;fhuk>; fw;Gu rpyhrj;J tiff;F 1 gyk; 
vYkpr;rk;gor;rhw;whyhl;b tpy;iyjl;b Rz;zhk;G Fifapy; 
itj;J rpWGlk;Nghl;L 1 tuhfndil Njdpy; nfhLf;f 
ePuilg;G> fy;yilg;G> ntl;il> fLg;G> gpuNkfk; jPUk; 
Rj;jp KiwfSf;F vYkpr;rk; gor;rhW: 
 fLif vYkpr;rk; gor;rhw;wpy;  Cwitj;J vLf;f Rj;jpahk;. 
 frj;jpg;gpypia vYkpr;rk; gor;rhw;wpy;  Cwitj;J vLf;f Rj;jpahk;. 
 Ckj;jk; tpijia vYkpr;rk; gor;rhw;wpy;  Cwitj;J vLf;f Rj;jpahk;. 
 ,Uk;ig eWf;fp vYkpr;rk; gor;rhw;wpy;  Cwitj;J vLf;f Rj;jpahk;. 
 fhe;jj;ij Nkhh;fhb kw;Wk; vYkpr;rk; gor;rhw;wpy; jdpj;jdpNa Cwitj;J 
vLj;j Rj;jpahk;.34 
 vYkpr;irtpij tplk; KwpT: 
Gspg;ghd vYkpr;ir tpijfis rhg;gpl;l tp\j;jpw;F ifahe;jfiu 
,iyia miuj;Jf; nfhLf;fTk; 
eQ;R FwpFzk; 
 vYkpr;rk; rhW kpFjpahfg; gad;gLj;jpdhy; jiy ,jaj;jpYs;s euk;Gfs; 
Fly; vd;Dkptw;wpf;Ff; nfLjy; tpistpf;Fk;. 
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eQ;R KwpT 
Njd;> rf;fiu> cg;G> NghPl;rk;gok; rhW> KUq;ifg;gl;ilr;rhW vd;gd 
Kwpg;GfshFk;.36 
NrUk; gpw kUe;Jfs;: 
nghd;dhpjhu gw;gk;:36 
msT: 1 gzntil(488 kp.fp) 
jPUk;Neha;fs;: rPjRuk;> ehd;fhk; Kiwf;fha;r;ry;> gTj;jpuk;> fpue;jpGz;> #iy. 
rd;dpthj itutk;:37 
msT: cSe;jsT 
jPUk;Neha;fs;: tplRuq;fs;> rd;dp> <is> ,Uky;. 
Mde;j itutk;: 
msT: cSe;jsT 
jPUk; Neha;fs;: thjRuk;> rd;dp> Fsph;Ruk;. 
kfh$o;ghz;l Nyfpak; 
msT  : 5 tuhfndil 
jPUk; Neha;fs;: m];jp fuk;> Nrhif> fhkhiy> gpukpak; 
Rth;zG+gjp Fspif 
msT  : 1 khj;jpiu 
jPUk; Neha; : re;jpj;Njhlk;> <is> fhrk;> ePhpopT> kNfhjuk;. Kfthjk; 
ghlhzRz;zk; 
msT  : 2 mhprp gpukhzk; 
mDghdk; : Njd;> nea; 
jPUk; Neha; : re;jpNjhl Ruq;fisAk; fz;bg;gha; ghpfhpf;Fk; 
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etkzpr;nre;J}uk; 
msT  : ½-1 Fd;wp vil 
mDghdk; : Njd; 
jPUk; Neha; : #jff;fl;b> ngUtapW md;wpAk; #jfr;rpf;fy; 3 Ntisapy; 
jPUk; 
ypq;ff;fl;L nre;J}uk; 
msT  : 2 mhprp gpukhzk; 
mDghdk; : Njd; 
jPUk; Neha; : rd;dp> thjr;Ruq;fs; FzkhFk; 
,Q;rp urhadk;38 
msT  : ney;ypf;fha;g; gpukhzk; 
jPUk; Neha; : the;jp> eLf;fy;> fopr;ry;> Uj;jpthA 
rpj;jhjp Nyfpak; 
msT  : nfhl;ilg;ghf;Fg; gpukhzk; 
jPUk; Neha; : ghz;L> thA> mf;dp ke;jk;> Nrhif 
nghd;dhq;fzp nea; 
msT  : 1 fuz;b 
jPUk; Neha; : Nkf fhq;if> iffhnyhpT> tha; ehw;wk;> gpukpak; 
ma rk;gPu fw;gk; 
msT  : gpsT xd;W 
jPUk; Neha; : ghz;L> Nrhig Neha; 
jphpNyhfr;nre;J}uk; 
msT  : gzntil(488 kp.fp) 
mDghdk; : rQ;rPtp #uzk; 
jPUk; Neha; : ghz;L> gpj;jk;> gpuNkfk;> thA 
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ehuhazkz;^uk; 
msT  : Gspaq;nfhl;ilasT 
mDghdk; :  nte;ePh;> Nkhh; 
rd;dpthj itutk; 
msT  : cSe;jsT(65 kp.fp) 
jPUk; Neha;fs;: rd;dp> <is> ,Uky;> tplfuk; 
nrhh;j;njz;iza;j; ijyk; 
msT  : 1.33 kp.yp 
jPUk; Neha;fs;: thjk; vd;gJ> typg;G> re;jp 
Nfrhp ,Nyfpak; 
msT  : 1-2 tuhfd; 
jPUk; Neha;fs;: gpj;jk;> md;dntWg;G> tapw;Wtyp> gpj;jthA 
rhjp rk;gPuf;Fok;G15 
msT  : fhy; Kjy; 1 Fd;wp 
jPUk; Neha;fs;: the;jp> tpf;fy;> jhfk;> ghz;L> ntg;G> %h;r;ir 
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CITRUS LIMON 
VERNACULAR NAMES:
39 
Eng  : Lime      
Hin  :Jamiri nimbu 
Kan  :Limbe 
Mal  :Cerunarakaram 
San  :Jambirah 
Tam  :Elumichai 
Tel  :Peddanimma , Nimma 
Unani :Leemu , Baraa , Neebu 
BOTANICAL ASPECT OF LEMON: 
CLASSIFICATION   
KINGDOM  :Plantae-plants  
SUBKINGDOM : Trachaobionta-vascular plants  
SUPER DIVISION :Spermatophyte-Seed plants 
DIVISION  :Magnoliopsida-flowering 
CLASS  :Magnoliopsida-dicotyledons 
SUBCLASS  :Rosidae 
ORDER  :Sapindales 
FAMILY  :Rutaceae 
GENUS  :Citrus  
SPECIES  :Limon
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DISTRIBUTION: 
  Throughout india, cultivated in plants and hills in area up to 1200 meter 
elevation. Commonly found in kumaon parts of Himalayas, northern and central India. 
THE PLANT: 
  A much branched thorny shrub with spreading branches leaves the 
unifoliately  compound, rachis winged, leaflet elliptic-oblong, alternate, coriaceous, 
entire or crenulated, flowers white in short racemes, fruits large, globose berries with 
thick or thin rind, pulp pale, very acid, seeds many, horizontal, testa coriaceous. 
PARTS USED: 
  Fruits  
ALKALOIDS: 
  Limonene is a principal constituent of essential oil, others are citronella,          
n-nonanal, n-decanal, n-dodecanal, linalyl-acetate, citronellyl acetate, methyl 
anthranilate, lipophilic flavonoids including sinesetin and furocoumarins. 
       The chief flavonoids are naringin, and neohesperidin, dihydro chalcones 
hesperidone and rutin. It also contains glycosyl apigenin, p-caryophyllene, limocitrol, 
limocitrin, abscisic acid, gibberellic acid, abscisin II, auxin and isorhamnetin.
 40  
CHEMICAL CONSTITUENTS OF LEMON:  
         Lemon and other citrus fruits contain different chemicals and thought to have 
some health benefits. They contain a terpene called limonene which gives their 
characteristic lemon smell and taste. Lemon contains the significant amount of citric 
acid, that is why they have a low PH and a sour taste. They also contain vitamin C 
(ascorbic acid) which is essential to human health.  
  100 millilitres of lemon juice contains approximately 50mg of vitamin C(55 % 
of the recommended daily value ) and 5 gms of citric acid.  
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NUTRIENTS – AMOUNT :41 
 Calories – 15.25 
 Carbohydrate- 5.27g 
 Sugar total - 2.08g 
 Fat total -0.00g 
 Protein  -0.15g 
VITAMINS
42
 
 Vitamin A (IU) -12.20 
 Thiamine B1 – 0.02mg 
 Riboflavin B2 – 0.01mg  
 Niacin B3 – 0.06mg 
 Vitamin B6 – 0.03mg 
 Vitamin B12 – 0.00mg 
 Vitamin C – 28.06mg 
 Folate  - 7.87mcg 
 Pantothenic acid – 0.07mg 
 Biotin – 0.19mcg 
 Vitamin k -0.00mg 
VitaminE – 0.14mg 
MINERALS : 
 Calcium – 4.27mg 
 Copper – 0.02mg 
 Iron -0.05mg 
 Magnesium -3.66mg 
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 Manganese – 0.01mg  
 Selenium – 0.06mg 
 Potassium - 62.83mg 
 Phosphorus - 4.88mg 
 Sodium – 0.61mg 
 Zinc – 0.03mg 
 Selenium – 0.06mcg 
ACTION: 
Stomachic and Carminative 
OIL: 
 It is bitter, aromatic , stomachic and carminative  
JUICE:  
 The expressed strained juice of the ripe fruit is a valuable antiscorbutic and 
refrigerant, primarily anti alkaline and secondarily antacid. 
BARK: 
 It is used as febrifuge and seeds as a vermifuge. The Pulp is exceedingly acid.  
MEDICINAL USES OF LEMON :
43 
 Juice of the baked lemon is an excellent remedy for a cough when mixed with an 
equal quantity of sugar or honey and taken in teaspoonful doses. 
 Fresh lemon juice is recommended to be taken in the evening for the relief 
dyspepsia with vomiting and bilious headaches. 
 Preserved with sugar or honey lemons are recommended for a sore throat and are 
considered to act as detergent they are administered before purgatives to prepare 
the body for them and afterwards to check excessive action. 
 Lemon plays an important part in perfumery also. The quality of Indian peel is 
almost equal to the Sicilian variety and it has been estimated that if extraction of 
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lemon oil is attempted from the Indian lemon peel, It will not be a failure 
commercially  
 The rind of the fruit is sour, heating, with a sharp taste; anthelmintic; removes 
"vata", "kapha", lung troubles. 
 The rind of the ripe fruit is stomachic and carminative. The oil mixed with 
glycerine is applied to the eruption of acne. 
 The juice of the ripe fruit is a valuable antiscorbutic and refrigerant. 
 In scurvy, it is one of the best remedies we possess, both as a prophylactic and as 
a curative. 
 In acute rheumatism and rheumatic gout, in some forms of acute tropical 
dysentery and diarrhoea,etc., it has been successfully employed.
49
 
 As an antidote to some acro-narcotic poisons, it often proves effectual. 
 The fruit in the form of pickles is useful in hypertrophy of spleen. Lemon peel is 
stomachic and carminative. 
CANCER 
In an experiment with the flavonoid eriocitrin and its metabolites and with 
coumarins extracted from lemon fruit, apoptosis has been demonstrated in acute 
myelomonocytic leukemia cells 
ADVERSE REACTIONS 
Lemon juice may cause loss of gloss, alteration in enamel colour and irregular 
dental tissue on tooth enamel.Anaphylactic allergy to lemon soap has been reported 
resulting from a possible cross sensitivity of citrus seed to peanut allergen
50 
RECENT RESEARCHES ABOUT LEMON JUICE: 
1.DIURETIC AND ANTIHYPERTENSION ACTIVITY
44
 
 Lemon juice is value in hypertension and Urinary diseases if used in the form of 
reconstituted Lemon drink (from powder pocket). Traditionally lemon juice has a vast 
number of uses including its anti-oxidant properties, anxiolytic, antidepressant effect as 
well as diuretic potential. 
2.HEALTH AND MEDICINAL PROPERTIES OF LEMON:
45 
 Vitamin C present in the lemon juice. So it cures scurvy. Lime juice and its oil 
are very beneficial for skin when consumed orally or applied externally. Lime juice has 
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an irresistible scent which waters the mouth and thus aids primary digestion. Primarily, 
the ample of acids present in lime helps clear the excretory system by washing and 
cleaning off the tracts, just like some acids are used to clean floor and toilets. An 
overdose of lime juice with salt also acts as an excellent purgative without any side 
effects, thereby giving relief in constipation.
   
3.ANTIBACTERIAL ACTIVITY OF FRUITS AGAINST ESCHERICHIA COLI:
 The lemon juice contains Antibacterial activity against E.coli.More organisms 
can undoubtedly be analysed for this antibacterial activity. Numerous fruits are 
unquestionably utilized to prevent foodborne illness diseases.
 46
 
4.LEMON POLYPHENOLS  SUPPRESS DIET-INDUCED OBESITY: 
 Lemon polyphenols suppress Diet-induced Obesity by up-Regulation of mRNA 
levels of the Enzymes Involved in β-oxidation in mouse white adipose tissue. Feeding 
with lemon polyphenols suppressed body weight gain and body fat accumulation by 
increasing peroxisomal β-oxidation through up-regulation of the mRNA level of ACO 
(acetyl CoA oxidase ) in the liver and white adipose tissue, which was likely mediated 
via up-regulation of the mRNA levels of PPARα. 47 
5.PROTECTIVE EFFECTS OF LEMON JUICE ON ALCOHOL-INDUCED 
LIVER INJURY: 
 Chronic excessive alcohol consumption (more than 40-80g/day) could induce 
serious liver injury. Histopathological changes induced by alcohol were also remarkably 
improved by lemon juice treatment. These findings suggest that lemon juice has 
protective effects on alcohol-induced liver injury in mice. The protective effects might 
be related to the antioxidant capacity of lemon juice because lemon juice showed in vitro 
antioxidant capacity.
 49
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4. MATERIALS AND METHODS 
4.1. Preparation of the test drug: 
Selection of the test drug: 
The test drug Annabethi chendhuram was selected for the evaluation of toxicity 
studies in Wistar albino rats. 
Ingredients of Annabethi chendhuram: 
Annabethi      - 1 balam (35g) 
Lemon juice   - Sufficient quantity 
Procurement of the Raw drug: 
Annabethi (Ferrous sulphate) was procured from a reputed shop in Chennai. 
Lemon was procured from Tambaram market, Chennai. 
Identification of Annabethi: 
Annabethi was identified by its blue-green appearance, Crystalline in nature, 
Water soluble salt. 
Authentication of the Raw drug 
The Herbal drug was identified and authenticated by Botanist, NIS Tambaram 
Sanatorium Chennai (Certificate No: NISMB2852017 ), The Annabethi was 
authenticated by HOD of the Gunapadam Department, NIS Tambaram Sanatorium 
Chennai. 
The purification process of Annabethi 
The juice of lemon fruit (Citrus lemon) was poured over the Annabethi till the 
powder is immersed in the juice. It was then kept in sunlight until the juice was 
completely dried and then gets the purified Annabethi. 
Method of preparation 
35g purified ferrous sulphate was placed in the kalvam and it was ground with 
the lemon juice. Then the grinding substance was made into a cake and dried it. After 
MATERIALS AND METHODS 
36 
 
that, it was put in a flask and calcined (pudam process ) twice or thrice if necessary till a 
dark red colour appearance. The chendhooram should be reddish purple in colour. The 
above-prepared chendhuram was kept in an airtight glass container.  
Indication: 
 Paandu (Anaemia) 
 Suram (Fever) 
 Seetha Bethi (Dysentry) 
Dosage: 
65-130mg (1/2 to 1 kundri). 
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PREPRATION OF ANNABETHI CHENDURAM 
 
 
 
A.Raw Annabethi    B.Lemon dissolved annabethi 
C.Purified Annabethi    D.Annabethi with lemon before 
 pudam 
E. Mud plate           F. Pudam (Calcined process) 
G..Annabethi chendhuram after pudam H. Annabethi chendhuram after 
trituration. 
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ANALYTICAL STUDY OF ANNABETHI CHENDHURAM 
The Annabethi chendhuram was subjected to following analytical studies like 
physicochemical analysis, Biochemical Analysis and Quantitative analysis by using 
sophisticated instruments. 
4.2QUALITATIVE ANALYSIS 
The Annabethi chendhuram was studied by physicochemical parameters. This 
study was done at The Tamil Nadu Dr.M.G.R. Medical University No.69, Annasalai, 
Guindy, Chennai-600032. 
A.PHYSICO-CHEMICAL PROPERTIES 
1.LOSS ON DRYING: 
An accurately weighed 2g of Annabethi Chendhuram formulation was taken in a 
tarred glass bottle. The crude drug was heated at 105
o
C for 6 hours in an oven to a 
constant weight. Percentage moisture content of the sample was calculated with 
reference to the shade-dried material.
 48 
Calculation: 
                                                                   Loss in weight of test drug 
Percentage of loss on drying at 105
o
C =  ------------------------------------- ×100 
                         Weight of test drug taken  
2.DETERMINATION OF TOTAL ASH: 
Weighed accurately 2g of Annabthi chendhuram formulation was added in the 
crucible at a temperature 600
o
C in a muffle furnance till carbon-free ash was obtained. It 
was calculated with reference to the air-dried drug.
 48 
Calculation: 
      Weight of the ash    
                  Percentage of total ash = --------------------------------- ×100 
               Weight of test drug take 
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3.DETERMINATION OF ACID INSOLUBLE ASH: 
 Ash above obtained, was boiled for 5min with 25ml of 1M Hydrochloric acid 
and filtered using an ashless filter paper. Insoluble matter retained on filter paper was 
washed with hot water and filter paper was burnt to a constant weight in a muffle 
furnace. The percentage of acid insoluble as was calculated with reference to the air-
dried drug.
 48 
Calculation: 
               Weight of the acid-insoluble residue 
Percentage of acid-insoluble ash = ---------------------------------------------×100 
         Weight of test drug taken  
4.DETERMINATION OF WATER-SOLUBLE ASH:  
Total ash 1g was boiled for 5min with 25ml water and insoluble matter collected 
on an ash less filter paper was washed with hot water and ignited for 15 min at a 
temperature not exceeding 450
o
C in a muffle furnace. The amount of soluble ash is 
determined by drying the filtrate.
 48 
5.DETERMINATION OF WATER-SOLUBLE EXTRACTIVE:  
 5gm of air-dried drug, coarsely powered Annabethi Chendhuram was macerated 
with 100ml of distilled water in a closed flask for twenty –four hours, shaking 
frequently. The solution was filtered and 25 ml of filtered was evaporated in a tarred flat 
bottom shallow dish, further dried at 100
o
C
 
and weighed. The percentage of water-
soluble extractive was calculated with reference to the air-dried drugs.
 48 
Calculation:
 
             Weight of the extract          100 
Percentage of water-soluble extract =  ---------------------------------×  --------     ×  100 
                                                                Weight of test drug taken      25 
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B.CHEMICAL EVALUATION 
EXPERIMENTAL PROCEDURE 
5g of Annabethi Chendhuram was taken in a 250 ml of clean beaker and 50ml of 
distilled water was added it. Then it was boiled well for about 10 min. Then it is allowed 
to cool and filtered into a 100 ml volumetric flask and made up to 100 ml with distilled 
water. This preparation is used for the qualitative analysis of acidic/basic radicals and 
biochemical constituents in it. The biochemical analysis of Annabethi Chendhuram was 
done at Biochemistry Lab, National Institute of Siddha, Chennai-47. 
A Preliminary Test For Copper, Sodium, Silicate And Carbonate: 
 
S.NO 
           
           EXPERIMENT 
                                                         
OBSERVATION 
 
    
 INFERENCE 
1. The appearance of the sample Dark brown in colour  
 
2. 
 
SOLUBILITY: 
a. A little of the sample is 
shaken well with distilled 
water 
b. A little of the sample is 
shaken well with 
con.HCL/con.H2SO4 
 
Sparingly soluble 
 
 
 
Completely soluble 
 
 
 
Presence of silica 
3. ACTION OF HEAT: 
 A small amount of the sample is 
taken in a dry test tube and heated 
gently at first and then strong 
 
No white fumes 
 
 
No brown fumes 
 
Absence of 
Carbonate 
 
Absence of Nitrate 
4. FLAME TEST: 
 A small amount of the sample is 
made into a paste with con.HCL in 
a watch glass and introduced into a 
non-luminous part of the Bunsen 
flame. 
 
No Bluish green 
flame appeared. 
 
Absence of Copper 
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TEST FOR ACID RADICALS 
3. 
 
 
 
 
TEST FOR PHOSPHATE: 
 2ml of the extract is treated with 
2ml of ammonium molybdate 
solution and 2ml of con.Hno3. 
 
Cloudy Yellow 
appearance present 
 
Presence of 
phosphate 
4. 
 
 
 
TEST FOR CARBONATE: 
 2ml of the extract is treated 2ml 
magnesium sulphate solution 
 
Cloudy appearance  
 
Presence of 
Carbonate 
5. TEST FOR NITRATE: 
 1 gm of the substance was heated 
with copper turnings and 
concentrated H2SO4 and viewed the 
test tube vertically down. 
 
No characteristic 
changes 
 
Absence of Nitrate 
5. ASH TEST: 
 A filter paper is soaked into a 
mixture of sample and cobalt 
nitrate solution and introduced into 
the Bunsen flame and ignited. 
 
 
 
No Yellow colour 
flame appeared. 
 
Absence of sodium 
1. 
 
 
 
TEST FOR SULPHATE: 
 2ml of the above-prepared extract 
was taken in a test tube to this 
added 2ml of 4% ammonium 
oxalate solution.  
 
Cloudy appearance 
absent 
 
Absence of sulphate 
2. TEST FOR CHLORIDE: 
 2ml of the above-prepared extract 
was added with dil.Hno3 till the 
effervescence ceases. Then 2 ml of 
silver nitrate solution is added. 
  
No cloudy 
appearance  
 
Absence of chloride 
MATERIALS AND METHODS 
42 
 
6. TEST FOR SULPHIDE: 
 1 gm of the substance is treated 
with 2ml of con.HCL 
2ml of the extract was added 
 
No Rotten egg 
smelling gas evolved 
 
Absence Sulphide 
7.  TEST FOR FLUORIDE 
&OXALATE: 
with 2 ml of dil. acetic acid and 2ml 
calcium solution and heated  
 
No cloudy 
appearance  
 
The absence of 
fluoride and oxalate 
8. TEST FOR NITRITE: 
 3 drops of the extract were placed 
on a filter paper, on that- 2 drops of 
Benzidine solution was placed 
 
 
No characteristic 
changes 
 
Absence of nitrite 
9. TEST FOR BORATE: 
 2 pinches of the substance were 
made into the paste by using 
sulphuric acid and alcohol(95%) 
and introduced into the blue flame. 
 
Bluish green colour 
flame not appeared 
 
Absence of borate 
TEST FOR BASIC RADICALS 
1. TEST FOR LEAD: 
 2ml of the extract is added with 
2ml of potassium iodide solution  
  
Yellow precipitate 
was obtained 
 
Presence of lead 
2. TEST FOR COPPER: 
 One pinch of substance was 
made into the paste with 
con.HCL in a watch glass and 
introduced into the non-luminous 
part of the flame 
 
No Blue colour 
flame appeared 
 
Absence of copper 
3. TEST OF ALUMINIUM:               
 To the 2ml of the extract, 
sodium hydroxide was added in 
drops to excess 
Yellow colour 
formed  
Presence of  copper 
MATERIALS AND METHODS 
43 
 
4. TEST FOR IRON: 
a.To the 2ml of extract 2ml 
ammonium solution. 
 
b.To the 2ml of extract, 2ml     
thiocyanate solution and 2ml of 
con.HNO3 was added. 
 
Presence of brown 
precipitate 
 
 
Blood red colour 
appeared 
 
 
 
Presence of iron 
  5. TEST FOR ZINC: 
 To 2ml of the extract, sodium 
hydroxide solution was added in 
drops to excess.  
 
The white 
precipitate was 
formed 
 
Presence of Zinc 
  6. TEST FOR CALCIUM: 
 2ml of the extract was added 
with 2ml of 4% ammonium 
oxalate solution 
 
Cloudy appearance 
and the white 
precipitate was 
obtained 
 
Absence of calcium 
7. 
 
TEST FOR MAGNESIUM: 
 To 2ml of extract, sodium 
hydroxide solution was added in 
drops to excess 
 
The white 
precipitate was 
obtained 
 
Presence of magnesium 
 
 
8. TEST FOR AMMONIUM: 
 To 2ml of extract few ml, 
Nessler’s reagent and excess of 
sodium hydroxide solution were 
added 
 
No Brown colour 
appeared 
 
Absence of Ammonium  
9. TEST FOR POTASSIUM: 
A pinch of substance was treated 
with 2ml of sodium nitrite 
solution and then treated with 
2ml of cobalt nitrate in 30% 
glacial acetic acid. 
 
 
 
No Yellowish 
precipitate was 
obtained 
 
Absence of potassium 
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10. TEST FOR SODIUM: 
 2 pinches of the substance are 
made into a paste by using HCL 
and introduced into the blue 
flame of Bunsen burner 
 
No Yellow colour 
flame appeared 
 
 
Absence of sodium 
 
11. TEST FOR MERCURY: 
 2ml of the extract was treated 
with 2ml of sodium hydroxide 
solution 
 
No Yellow 
precipitate was 
obtained  
 
Absence of mercury 
12. TEST FOR ARSENIC: 
 2ml of the extract was treated 
with 2ml of sodium hydroxide 
solution 
 
No brownish-red 
precipitate was 
obtained 
 
Absence of arsenic 
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MISCELLANEOUS 
1. TEST FOR STARCH: 
 2ml of the extract was treated 
with weak iodine solution 
 
No blue colour 
developed 
 
Absence of starch 
2. TEST FOR REDUCING 
SUGAR: 
 5ml of Benedict’s qualitative 
solution is taken in a test tube 
and allowed to boil for 2 
minutes and added 8 to 10 
drops of the extract and again 
boil it for 2 minutes. The colour 
changes were noted. 
 
 
Brick red colour not 
developed 
 
 
The absence of 
reducing sugar 
3. TEST FOR THE 
ALKALOIDS: 
a.2 ml of the extract was treated 
with 2 ml of potassium iodide 
solution 
b.2 ml of the extract was treated 
with 2 ml of picric acid 
 
 
Red colour 
developed 
 
Yellow colour 
developed 
 
 
Presence of alkaloid 
 
4. TEST FOR TANNIC ACID: 
 2 ml of extract was treated 
with 2 ml of ferric chloride 
solution 
 
No black precipitate 
was obtained 
 
An absence of 
tannic acid 
5. TEST FOR UNSATURATED 
COMPOUND: 
 To  the 2 ml of the extract, 2 
ml of potassium permanganate 
solution was added  
 
 
Potassium 
permanganate was 
not decolourised 
 
 
The absence of 
Unsaturated 
compound 
6. TEST FOR AMINO ACID: 
 2 drops of the extract were 
placed on a filter paper and 
dried well  
  
No violet colour 
developed   
 
Absence of amino 
acids 
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7. TEST FOR TYPE OF 
COMPOUND: 
 2 ml of the extract was treated  
With 2 ml of ferric chloride 
solution 
 
 
 
 
 
 
 
 
 
 
 
 
No green colour 
developed 
 
 
 
No Red colour 
developed 
 
 
 
The absence of 
oxyquinoline 
epinephrine and 
pyrocatechol.  
 
Anti pyrine, 
Aliphatic   amino 
acids    and                    
meconic         acid 
were present. 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
47 
 
4.3 QUANTITATIVE ANALYSIS 
1. FOURIER TRANSFORM INFRARED SPECTROSCOPY(FTIR) 
      
Fourier transform infrared spectroscopy(FTIR) is a technique which is used 
to obtain an infrared spectrum of absorption or emission of a solid, liquid or gas. An 
FTIR spectrometer simultaneously collects high spectral resolution data over a wide 
spectral range. This confers a significant advantage over a dispersive spectrometer which 
measures intensity over a narrow range of wavelengths at a time. The term Fourier 
transform infrared spectroscopy originates from the fact that a Fourier transform (a 
mathematical process) is required to convert the raw data into the actual spectrum.For 
other uses of this kind of technique, see Fourier transform spectroscopy. 
The standard method to prepare a solid sample for FTIR spectrometer is to use 
KBr. About 2mg of Annabethi Chendhuram and 200mg KBr are dried ground. The 
particle size should be unified and less than two micrometres. Then, the mixture is 
squeezed to form transparent disc which can be measured directly. For liquids with a 
high boiling point or a viscous solution, it can be added between two NaCl pellets. Then 
the sample is fixed in the cell by skews and measured. For a volatile liquid sample, it is 
dissolved in CS2 or CCL4 to form 10% solution. Then the solutions are injected into a 
liquid cell for measurement. Gas sample needs to be measured in a gas cell with two KBr 
windows on each side. That gas cell should first be vacuumed. Then the sample can be 
introduced into the gas cell for measurement. 
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2.SCANNED ELECTRON MICROSCOPY(SEM) 
 
An SEM is essentially a high magnification microscope, which uses a focused 
scanned electron beam to produce images of the sample, both top-down and, with the 
necessary sample preparation, crosses sections. The primary electron beam interacts with 
the sample in a number of key ways:- 
 A primary electron generated low energy secondary electron, which tends to 
emphasize the topographic nature of the specimen. 
 A primary electron can be backscattered which produces images with a high 
degree of atomic number (Z) contrast. 
 Ionized atoms can relax by electron shell-to-shell transitions, which lead to either 
X-ray emission or Auger electron ejection. The X-ray emitted are characteristic 
of the elements in the top few µm of the sample. 
The SEM is carried out by using FEI-Quanta FEG 200-High Resolution Instrument. 
RESOLUTION:1.2nm gold particle separation on a carbon substrate 
MAGNIFICATION: From a min of 12x to greater than 1,00,000X  
APPLICATION: To evaluate grain size, particle size distributions, material 
homogeneity and intermetallic distributions. 
Calculation of the particle size: 
The horizontal line in the right corner of the micrograph corresponds to the 
micron inlength would be given. A comparison could be made between the length of the 
particlesvisible in the micrograph with this line and the length of the particle was 
calculated. 
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3.HEAVY METAL ANALYSIS 
3.1ATOMIC ABSORPTION SPECTROMETER(AAS) 
ESTIMATION OF HEAVY METALS: 
The procedure recommended for analysis of Heavy metals like Lead, Cadmium, 
Arsenic, and Mercury in WHO,1998 and AOAC,2005. Iron was analysed by the standard 
method. 
INSTRUMENT DETAILS: 
Uv-Vis spectrometer AA240 series 
Test method- USP 231 USP 39 NF 34 
SAMPLE DIGESTION: 
 Test sample ABC digested with 1 mol/L of HNO3. 
STANDARD PREPARATION: 
Fe -100 ppm sample in 1 mol/L HNO3. 
 AAS has used for determining the Iron concentration in the Annabethi 
Chendhuram. 
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ICP- OES 
The analysis of heavy metals and trace elements were estimated by using 
Inductively coupled plasma optical emission spectrometry (ICP- OES). The 
Experimental Procedure was done at SAIF, IIT Madras, Chennai-36. 
3.2 INDUCTIVELYNCOUPLED OPTICAL EMISSION SPECTROMETRY 
 (ICP-OES): 
Perkin Elmer Optima 5300DV was used for standard ICP-OES analysis. The 
optimized operating conditions, the wavelength of analytical lines are given in table (A) 
and the test drug Annabethi Chendhuram (ABC) underwent microwave digestion for 
sample preparation. 
Table (A): ICP- OES Operating Conditions 
Rf frequency 40 M Hz 
Range 165-782 nm 
Detection limit Up to ppm level using SCD detector 
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4.4TOXICITY STUDIES OF ANNABETHI CHENDHURAM 
To evaluate the safety profile of Annabethi chendhuram acute and subchronic 
study toxicity study carried out as followed 
 Principles of laboratory animal care were followed and the Institutional Animal 
Ethics Committee approved the use of animals and the study design. Institutional Animal 
Ethics Committee number : (IAEC). (NIS/IAEC-II/12/2016) dated 29.9.2016. 
1. ACUTE TOXICITY STUDY OF ANNABETHI CHENDHURAM 
            Species   : Wistar Albino Rats  
 Sex    : Male and Female  
 Age/weight  at start of test : 6 weeks/140-160g b.wt 
 Acclimatization Period : 7 days prior to dosing 
 Housing   : Polypropylene cages 
 Husbandry   : 12-h light/12-h dark artificial  
        photoperiod/ Room temperature  
                   22°C(±3°) and relative humidity  
                  30–70% 
 Feed and Water  :  Rodent pelleted feed    
                            RO purified water ad libitum 
         Identification   : Animals will be kept in individual  
                 cages and numbered 
Experimentation Details of Acute toxicity study :  
            Groups/treatment regimen : Grouped by randomisation 
 Test guideline   : WHO 
 Length of exposure to  
 test substance   :           Single Dose 
 No of animals  :  5Male+5 Female /group  
            Control group   : Vehicle 
            Test group   : Annabethi chendhuram. 
The both sex Albino rats of weighing 140-160 g were obtained from authorized 
animal breeders of the animal laboratory in TANUVAS, Madhavaram, and Chennai and 
stocked in the animal house at National Institute Of Siddha, Chennai. Animals were 
housed in a cage at 25°C and have free access to standard rat pellet diet. The animals 
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were dosed with Annabethi chendhuram by oral route for one day and monitored for 
behavioural parameters for the first 4 hours after drug administration. Body weight of the 
animal will be monitored at weekly intervals. All Animals were weighed and sacrificed 
under the injection of thiopental sodium on the after 14
th
 day of drug administration. The 
toxicological effect was assessed on the basis of mortality and behavioral parameters. 
Preparation of Test Drug Doses: 
 
 
 
                                                                                               
 
                                                                               Total 20(10M+10F) 
Route of administration: 
 Oral route was selected because it is the normal route of clinical administration. 
Administration of Dose: 
 The animals were fasted (only food was withheld ) for 12hrs and weighed prior to 
dosing.Animals were used for each step. A single dose of the test drug  (250mg/kg/body 
weight) was consecutively administered by oral gavage using intubation cannula. The 
food was withheld for another 4hrs after dosing and administration of the drug.  
Observations 
Observation was made and recorded systematically and continuously observed after 
the substance administration as per the guidelines. 
 Mortality, behavioural changes  
 ½ hour, 1 hour, 2 hours,4 hours and up to 24- hour observation  
 All rats were observed twice daily  for 14 days 
 Body weight was observed once in a week. 
 Feed intake was calculated daily. 
 Water intake was calculated daily. 
a. Cage-side observation  
 Clinical observation includes Mortality, convulsion, tremor, sedation, excitation, 
abnormal gait, motor coordination, piloerection, head movements, reactivity to touch, 
gripping, grooming, exophthalmos, diarrhoea, salivation, lacrimation, posture, dyspnoea, 
coma. 
Groups No. of Rat 
Group I:  Vehicle control (Honey) 10(5M+5 F) 
GroupII: Test drug (Annabethi chenduram) –             
250mg/kg b.wt 
10(5M+5F)  
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b. Gross necropsy 
At the end of the 14
th
 day, all the animals were sacrificed by using the injection 
of pentothal sodium Gross necropsy includes an examination of the external surface of 
the body, all orifices, cranial, thoracic and abdominal cavities and their contents. Brain,  
lung, heart, spleen, liver, kidney, uterus, testes, ovary of all animals.  
LONG TERM  TOXICITY STUDY  OF ANNABETHI CHENDHURAM 
Experimental animals: 
            Species    : Wistar Albino Rats  
 Sex     : Male and Female  
 Age/weight at start of test  : 6 weeks/140-160g b.wt 
 Acclimatization Period  : 7 days prior to dosing 
 Housing    : Polypropylene cages with bedding with 
         husk 
 Husbandry    : 12-h light/12-h dark artificial  
                  photoperiod/ Room temperature  
                  22°C(±3°) and relative humidity  
                  30–70% 
 Feed and Water   : Rodent pelleted feed   
                              RO purified water ad libitum 
         Identification    :Animals will be kept in   
      Polypropylyne cages and numbered  
Experimentation details   
             Groups/treatment regimen  : Grouped by randomisation 
 Test guideline    : WHO 
 Length of exposure to  
 test substance    : 90 days 
 No of animas    : 10 Female +10 Male/group 
 Control group    :Vehicle(Honey) 
Test groups    :Annabethi chendhuram(Low,Mid,Higdose) 
Albino rats of both sexes are divided into four group. The first group treated as 
vehicle control and second, third, fourth group were treated with Annabethi chendhuram 
Low dose, Mid dose, and High dose respectively. The control animals were administered 
with honey as a vehicle. The other animals were treated with Annabethi chendhuram by 
orally for 90 days and it was monitored for behavioural parameters for daiky after drug 
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administration. Body weight of the animal was monitored at weekly intervals. The food 
and water intake were calculated daily. All animals were weighed and sacrificed at the 
end of the study (91 days ) by using the injection of Pentothal sodium. Blood was 
collected from the anaesthetized animals from the abdominal aorta. And the following 
investigations like Haematology, Biochemical analysis and Histopathology are done. 
Groups No. of Rats 
Group I:  Vehicle control (Honey)    20(10M + 10F) 
Group II: ABC- low dose (25mg/kg b.wt) 20(10M + 10F) 
Group III: ABC - Mid dose (125mg/kg 
b.wt) 
20(10M + 10F) 
GroupIV: ABC –High dose(250mg/kg 
b.wt) 
20(10M + 10F) 
         Total   80  ( 40 Female + 40 Male)      
Observations 
Experimental animals were kept under observation throughout the course of study for the 
following 
 Mortality, behavioural changes  
 All rats were observed twice daily  for  90 days 
 Body weight was observed once  a week. 
 Feed intake was calculated daily. 
 Water intake was calculated daily. 
Cage-side observation 
The animals were monitored for behavioural parameters like Alertness,  
Mortality, convulsion, tremor, sedation, excitation, abnormal gait, motor 
coordination,  piloerection, head movements, reactivity to touch, diarrhoea, 
salivation, lacrimation, posture, dyspnoea, coma. 
Laboratory investigation: 
On the 91st day, the animals were fasted overnight, then anaesthetized to collect 
blood samples from the abdominal aorta in two tubes: one with EDTA for 
haematological parameters, another one without any anticoagulant and was centrifuged 
at 4000 rpm at 4
0
C for 10 minutes to obtain the serum for biochemical parameters. 
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Clinical Biochemistry 
At the end of the study, the animals were sacrificed, blood was collected in all the 
overnight fasted rats, through abdominal aorta. The blood sample was processed for the 
below- mentioned investigations Lipid profile test (total cholesterol,HDL,LDL,VLDL, 
triglycerides) Liver function test(SGOT, SGPT,total bilirubin), Renal function test 
( creatinine, urea). 
Haematological Investigation: 
Blood samples of control and experimental rats were analysed for haemoglobin 
(Hb), total red blood corpuscles (RBC), White blood corpuscles (WBC) count, platelet, 
Mean corpuscular volume (MCV), Mean corpuscular haemoglobin (MCH), DC were 
calculated by an auto analyser.  
Gross necropsy 
All the animals were sacrificed on the 91st day. Gross necropsy includes an 
examination of the external surface of the body, all orifices, cranial, thoracic and 
abdominal cavities and their contents Brain, lung, heart, spleen, liver, kidney, testes, 
uterus, ovary of all animals were recorded.   
Histopathology 
The organs included liver, kidneys, spleen, brain, heart, lung and stomach of the 
animals were preserved, and they were subjected to histopathological examination. 
Control and highest dose groups animals were initially subjected to 
histopathological investigation. Various organs such as brain, heart, lung, liver, kidney, 
spleen, stomach, uterus, testes, ovary  were collected from all the animals and preserved 
in 10% buffered neutral formalin, sliced, 5 or 6μm sections and was stained with 
Haematoxylin and Eosin. Examined for histopathological changes. 
Statistical analysis: 
 Findings such as body weight changes, food consumption, water intake, 
haematology and biochemical analysis were subjected to One-way ANOVA Dunnet’s 
test using a computer software program followed by D Graph Pad Instat-3. 
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DOSE CALCULATION: 
Animal dose = Human dose X Conversion factor (For the rat 0.018)  
(Paged and Burner) 
130 X 0.018 = mg / 200 g 
  = mg X 5. 
Low dose = mg/ kg.b.wt 
Mid dose = Low dose X 5 
  = mg X 5. 
Mid dose = mg/ kg.b.wt 
High dose = Low dose X 10 
  = mg X 10 
High dose = mg/ kg.b.wt 
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5.RESULTS 
Results of Analytical studies on Annabethi Chendhuram 
5.1. QUALITATIVE ANALYSIS 
PHYSICO-CHEMICAL ANALYSIS 
Table 1: Physico-chemical properties of Annabethi chendhuram(ABC) 
 
S.No Parameters Percentage 
 1. Loss on drying 
 
3.03% 
 2. Total ash value 
 
68.68% 
 3. Acid-insoluble ash 
 
58.47% 
 4. Water soluble ash 
 
20.01% 
 5. Water soluble extraction 
 
41.63% 
 6. Alcohol soluble extraction 
 
3.8% 
  
Table 2: colour and nature of  Annabethi chendhuram(ABC) 
 
 S.No Parameters Results 
1. Appearance 
 
Dark brown 
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BIOCHEMICAL ANALYSIS  
Table3: Biochemical analysis of Annabethi chendhuram(ABC) 
  S.No                       EXPERIMENT INFERENCE 
 1. Test for ammonium 
 
- 
 2. Test for Sodium 
 
+ 
 3. Test for Magnesium 
 
+ 
 4. Test for Aluminium 
 
+ 
 5. Test for potassium 
 
- 
 6. Test for Calcium 
 
- 
 7. Test for Iron 
 
+ 
 8. Test for Zinc 
 
+ 
 9. Test for Arsenic 
 
- 
 10. Test for Mercury 
 
- 
 11. Test for Lead 
 
+ 
 12. Test for Sulphate 
 
- 
 13. Test for Chloride 
 
- 
 14. Test for Phosphate 
 
+ 
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 15. Test for Carbonate 
 
 
+ 
 16. Test for Fluoride &Oxalate 
 
- 
 17. Test for Starch 
 
- 
 18. Test for Reducing sugar 
 
- 
 19. Test for Alkaloids 
 
+ 
 20. Test for Aminoacids 
 
- 
 21. Test for Unsaturated compounds 
 
- 
 
(+) Present ; (-) Absent 
 The chemical analysisof ABC showed that the presence of Iron, Zinc, 
Magnesium, Aluminium, Sodium, Lead, Phosphate, Carbonate, Alkaloids. 
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5.2.QUANTITATIVE ANALYSIS 
SCANNED ELECTRON MICROSCOPE 
Image: 1  HR-SEM Analysis - Determination of particle size of  Annabethi   
Chendhuram 
 
 
 
RESULTS AND INTERPRETATION OF SEM ANALYSIS: 
    SEM images of Annabethi chendhuram clearly indicates that the particles are 
aggregated and present in nano and near-nano range. Most of the particles are spherical in 
shape. Majorly most of the particles are absorbed within 100nm. This medicine can be 
considered as nanomedicine. So, the bioavailability of the drug will be very high. The drug 
can act as more potent in small quantities. 
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EDAX ANALYSIS 
Image-2: EDAX Analysis of ABC  
 
 
Graph 1: 
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 Representing the Weight and atomic percentage of Elements present in ABC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
eZAF Smart Quant Results 
    
 Element Weight % Atomic % Net Int. Error % Kratio 
O K 9.23 26.45 1238.23 7.48 0.0579 
S K 4.98 7.12 1012.82 5.54 0.0462 
PbM 6.64 1.47 631.81 6.04 0.0618 
MnK 0.89 0.74 49.73 27.44 0.0088 
FeK 76.93 63.18 3505.70 3.10 0.7671 
CoK 1.33 1.03 47.45 25.49 0.0130 
 
RESULTS AND INTERPRETATION OF EDAX ANALYSIS: 
         The EDAX helps to identify the elements present in this test sample of 
Annabethi Chendhuram. Majorly the present of elements are Iron-76.93, Oxygen- 
9.23, Sulphur- 4.98 according to its weight. 
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FOURIER TRANSFORM INFRARED SPECTROSCOPY(FTIR) 
Graph 2: 
 
Table 4: FTIR analysis of Annabethi chendhuram 
Wave number(cm-1) 
 
Vibrational modes of 
ABC in IR region 
 
Functional groups 
3407 O-H stretch 
 
Alcohol 
2921 C-H  Stretch 
 
Alkane 
1624 C=CStretch 
 
Alkene 
1475 -C-O stretch 
 
Alkane 
1417 -C-H Stretch 
 
Alkane 
1365 C-F Stretch 
 
Alkyl halide 
1111 C-N Stretch Amine 
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844 =C-H Stretch 
 
Alkene  
798 =C-H Stretch 
 
Alkene  
672 C-ClStretch 
 
Alkyl halide 
594 C-Brstretch 
 
Alkyl halide 
542 C-Br stretch 
 
Alkyl halide 
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INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION SPECTROMETRY 
Table-5: Inductively Coupled Plasma Optical Emission Spectrometry of Annabethi Chendhuram 
 
S.NO ELEMENTS WAVELENGTH ( nm) ABC 
1. Aluminium 
 
Al 396.152 BDL 
2. Arsenic 
 
As 188.979 BDL 
3. Calcium 
 
Ca 315.807 06.170 mg/dl 
4. Cadmium 
 
Cd 228.802 BDL 
5. Copper 
 
Cu 327.393 BDL 
6. Iron 
 
Fe 238.204 221.320 mg/dl 
7. Mercury 
 
Hg 253.652 BDL 
8. Potassium 
 
K 766.491 03.071 mg/l 
9. Magnesium 
 
Mg 285.213 01.174 
10. Sodium 
 
Na 589.592 04.180 
11. Nickel 
 
Ni 231.604 BDL 
12. Lead 
 
Pb 220.353 BDL 
13. Phosphorus 
 
P 213.617 96.327 
(BDL-Below Detection Limit ) 
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RESULTS AND INTERPRETATION OF ICP –OES ANALYSIS: 
The presence of heavy metals such as mercury, lead, arsenic, cadmium is Below 
Detection Limit.. The presence of iron is 221.320mg/ dl, phosphorous-96.327mg/dl and 
some other elements are present in trace levels.  
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ATOMIC ABSORPTION SPECTROMETRY(AAS) 
Table 6: 
NAME ABSORPTION MAX RESULT ANALYSIS 
Iron-ABC 248.3 31.26 
 
REPORT AND INFERENCE OF AAS: 
 The total iron content of the sample ABC was performed by AAS.  ABC has the 
iron with  concentration of 31.26 ppm.  
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5.3 RESULTS OF TOXICITY STUDIES                    
ACUTE TOXICITY STUDY OF ANNABETHI CHENDHURAM 
 
Acute oral toxicity study of Annabethi Chendhuram 
In Acute toxicity study carried out as per WHO guidelines, there was no 
treatment-related death or signs of toxicity developed in Wistar albino rats at the dosage of 
10 times the therapeutic dose(250mg/kg b.wt) throughout the study period. 
Further, no gross pathological changes have been seen in the internal organs of 
both control and treated groups. 
Table 7: Effect of Annabethi chendhuram on Behaviour signs parameters  of Wistar 
albino rats 
N0 Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
1
7 
1
8 
1
9 
2
0 
 1 Control + - - + + + - - - - - - - - - - - - + - 
 2 
Test 
Group 
(ABC)    
250mg
/kg/b.
wt 
 
 
+ 
 
 
- 
 
 
- 
 
 
+ 
 
 
+ 
 
 
+ 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
+ 
 
 
- 
 
1.Alertness 2.Aggressiveness 3.Pile erection 4.Grooming 5.Gripping 6.Touch response 
7.Decreased Motor Activity 8.Tremors 9.Convulsion 10.Muscle spasm 11.Catatonia 
12.Muscle relaxant 13.Hypnosis 14.Analgesia 15.Lacrimation 16.Exopthalmos 
17.Diarrhoea 18.Writhing 19.Respiration 20.Mortality 
(+) Presence of activity 
 (-) Absence of activity 
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LONG TERM TOXICITY STUDY OF ANNABETHI CHENDHURAM 
BODY WEIGHT: 
  The Body weight changes were significantly increased when compared to control 
group.  
Table 8: Effect of Annabethi Chendhuram on Body weight changes of Wistar albino 
rats in a long-term toxicity study  
GROUPS DAY1 15 30 45 60 75 90 
CONTROL 127± 
12.41 
154.6± 
54.60 
221± 
74.67 
234± 
74.04 
252± 
74.97 
271.3± 
83.10 
297.7± 
66.6 
LOW 
DOSE 
122.6± 
20.5
 
241.6± 
50.36
**
 
244± 
54.88 
265.1± 
62.93 
279.6± 
68.64 
289± 
70.28 
294± 
72.28 
MID  
DOSE 
134.9± 
22.23 
249.1± 
40.93
**
 
260.3± 
49.71 
279.2± 
55.68 
288.8± 
61.43 
311.4± 
60.81 
317.2± 
59.25 
HIGH 
DOSE 
137± 
21.98 
190.3± 
36.98
**
 
253.3± 
51.63 
265± 
55.68 
278± 
58.16 
288.5± 
63.81 
292.6± 
65.28 
Values were expressed as mean± S.D. for N=10 rats in each group one-way 
ANOVA followed by Dunnett’s test. Significant indicates that *P<0.05, **P<0.01 
Graph 3: Body weight (g) changes of Wistar  albino rats treated to ABC 
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FEED INTAKE: 
 The Feed intake changes were significantly increased when compared to control 
group (Table 9).  
Table 9: Effect of Annabethi Chendhuram on food intake changes of Wistar albino 
rats in a long-term toxicity study  
GROUPS DAY1 15 30 45 60 75 90 
CONTROL 52.5± 
3.5 
64.5± 
3.53 
66.5± 
0.70 
66± 
2.82 
68.5± 
2.12 
69.5± 
0.70 
45± 
7.07 
LOW 
DOSE 
45± 
21.2 
40± 
14.12 
51.5± 
12.02 
52± 
22.62 
39.5± 
0.70 
49.5± 
0.70 
50± 
0.70 
MID 
 DOSE 
49± 
12.72 
45± 
21.2 
47± 
4.24 
41.5± 
4.94 
57.5± 
10.60 
60.5± 
3.53 
70± 
7.07 
HIGH 
DOSE 
40± 
7.07 
42.5± 
10.60 
57.5± 
7.77 
62.5± 
7.77 
65± 
14.14 
74.5± 
21.92** 
68.5± 
2.12* 
 
Values were expressed as mean± S.D. for N=10 rats in each group one-way ANOVA 
followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
Graph 4: Feed intake changes of Wistar  albino rats treated to ABC 
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WATER INTAKE: 
The Water intake changes were significantly increased when compared to control group 
(Table 10).  
Table 10: Effect of Annabethi Chendhuram on Water intake of Wistar albino rats in 
a long-term toxicity study  
GROUPS DAY1 15 30 45 60 75 90 
CONTROL 90± 
14.14 
75± 
7.07 
 
70± 
14.14 
70± 
14.14 
65± 
7.07 
65± 
7.07 
57.5± 
10.60 
LOW 
DOSE 
70± 
28.28 
60± 
28.28 
120± 
70.71
*
 
80± 
56.56 
90± 
42.42 
80± 
28.28 
85± 
7.07
**
 
MID 
DOSE 
95± 
63.63 
70± 
28.28 
100± 
42.42 
105± 
63.63 
95± 
7.07
*
 
120± 
84.85
*
 
90± 
28.28
**
 
HIGH 
DOSE 
100± 
42.42 
85± 
35.35 
110± 
28.28 
115± 
49.49 
85± 
21.21 
75± 
21.21 
110± 
14.14
**
 
Values were expressed as mean± S.D. for N=10 rats in each group one-way 
ANOVA followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
Graph 5: : Water intake changes of Wistar  albino rats treated to ABC 
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HAEMATOLOGICAL PARAMETERS: 
Haematological parameters were conducted at end of the study and the results were 
recorded. In test groups there was significant changes present in MCV (mid dose) when 
compared to control group.  
Table11 : Effect of Annabethi Chendhuram on Haematological parameters 
Parameter Control LD MD HD 
RBC (×10
6
µl) 6.86±1.12 6.41±2.05 6.96±1.05 6.83±1.13 
WBC(×10
3
µl) 8.86±2.38 9.06±1.76 9.9±2.40 8.5±2.56 
PLT(×10
3
µl) 637±169.52 698±207.18 722.5±163.5 714.6±177.01 
HB(g/dl) 13.24±1.30 12.4±1.59 13.93±1.34 13.33±1.064 
Neutrophils 
10
3
mm
3
 
1.74±0.55 1.67±0.65 1.71±0.66 1.75±0.55 
 
Eosinophil’s 
(%) 
1.33±0.18 1.46±0.3 1.47±0.66 1.5±0.25 
Lymphocyte(
%) 
76.84±9.11 79±9.24 77.02±11.55 78.45±14.47 
Monocyte(%) 3.18±0.65 2.58±0.98 3.36±1.26 2.6±0.84 
Basophils(%) 0.3±0.48 0.1±0.31 0.2±0.42 0.1±0.31 
MCH(pg) 18.44±2.08 19.79±3.06 19.39±2.68 17.79±2.53 
MCV (fl) 61.46±5.71 62.8±6.23 60.23±6.64
** 
61.51±5.25 
 
Values were expressed as mean± S.D. for N=10 rats in each group one-way ANOVA followed by 
Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
 
 
 
 
 
 
 
 
 
RESULTS 
 
73 
 
Graph 6: EFFECT OF ANNABETHI CHENDHURAM ON RBC
 
Graph 7: EFFECT OF ANNABETHI CHENDHURAM ON  WBC 
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Graph 8: EFFECT OF ANNABETHI CHENDHURAM ON PLATELET
 
 
Graph 9: EFFECT OF ANNABETHI CHENDHURAM ON HAEMOGLOBIN
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Graph 10:  EFFECT OF ANNABETHI CHENDHURAM ON DIFFERENTIAL 
COUNT
Graph 11: EFFECT OF ANNABETHI CHENDHURAM ON DIFFERENTIAL 
COUNT (LYMPHOCYTES) 
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Graph 12: EFFECT OF ANNABETHI CHENDHURAM ON DIFFERENTIAL    
COUNT (BASOPHILS) 
 
Graph 13: EFFECT OF ANNABETHI CHENDHURAM ON HAEMATOLOGY 
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BIOCHEMICAL PARAMETERS: 
Biochemical investigations were conducted at the end of the study and the results 
were recorded. In test groups, there were significant changes present in chemical 
parameters(TGL), when compared with control group. At the values were normal 
biochemical limits. (Table12) 
Table 12: Effect of Annabethi Chendhuram on Biochemical parameters 
 
Dose(mg/kg) 
 
Control 
 
LD 
 
MD 
 
HD 
Total 
cholesterol 
(mg/dl) 
 
155.47±17.87 
 
148.15±15.08 
 
148.8±19 
 
152.2±18.23 
 
HDL (mg/dl) 
 
60±8.13 
 
59.2±8.44 
 
59.6±7.96 
 
62.5±8.22 
 
LDL (mg/dl) 
 
72.7±13.78 
 
63±17.72 
 
70.7±9.77 
 
72.4±15.37 
 
VLDL (mg/dl) 
 
18.32±3.69 
 
16.73±4.19 
 
16.68±4.71 
 
17.93±3.36 
 
 
Triglycerides 
(mg/dl) 
 
30±10.36 
 
45.9±10.54
**
 
 
34.4±7.50 
 
13.6±12.48
**
 
 
Values were expressed as mean± S.D. for N=10 rats in each group one-way 
ANOVA followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
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Graph 14: EFFECT OF ANNABETHI CHENDHURAM ON BIOCHEMICAL  
PARAMETERS(LIPID PROFILE) 
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RENAL PARAMETERS 
Renal parameters were normal in test groups when compared to control group (Table-13) 
Table 13:   Effect of Annabethi Chendhuram on Renal Parameters 
Dose(mg/dl) Control LD MD HD 
BUN(mg/dl) 14.1±2.46 15.87±2.67 16.7±4.01 15.82±3.88 
Creatinine(mg/dl) 0.77±0.24 0.77±0.26 0.71±0.19 0.77±0.18 
Values were expressed as mean± S.D. for N=10 rats in each group one-way 
ANOVA followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
 
Graph 15:  EFFECT OF ANNABETHI CHENDHURAM ON RENAL 
PARAMETERS(BUN) 
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Graph 16: EFFECT OF ANNABETHI CHENDHURAM ON RENAL  
PARAMETERS (CREATININE) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
CREATININE
C
R
EA
TI
N
IN
E(
m
g/
d
l)
 
Control
Low dose
Mid dose
High dose
RESULTS 
 
81 
 
 
HEPATIC PARAMETERS: 
The results of the Liver function test conducted at the end of the study,  Renal parameters 
were normal in test groups when compared to control group (Table-14 ). 
 
Table 14:  Effect of Annabethi Chendhuram on Hepatic Parameters 
Dose(mg/dl) Control LD MD HD 
Total 
Bilirubin(mg/dl) 
0.32±0.13 0.33±0.13 0.39±0.16 0.35±0.08 
SGOT(U/L) 123.7±26.61 113.8±14.45 131±29.93 122.8±31.22 
SGPT(U/L) 34.4±6.29 32.1±8.73 27±9.28 35.3±5.98 
 
 
Values were expressed as mean± S.D. for N=10 rats in each group one-way ANOVA 
followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
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Graph 17: EFFECT OF ANNABETHI CHENDHURAM ON HEPATIC 
PARAMETERS(SGOT AND SGPT) 
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Graph 18: EFFECT OF ANNABETHI CHENDHURAM ON HEPATIC 
PARAMETERS (T.BILIRUBIN) 
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HISTOPATHOLOGICAL INVESTIGATION OF CONTROL AND 
ABC TREATED ANIMALS UNDER MAGNIFICATION POWER 
10X AND 40X FOR 90 DAYS LONG TERM TOXICITY STUDY: 
 
          HISTOPATHOLOGY OF BRAIN 
 
CONTROL    HIGH DOSE 
Low Power Magnification 10X Low Power Magnification 10X 
                  
 
High Power Magnification 40X   High Power Magnification 40X 
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CONTROL: 
The arrangement of the neurons appears intact with no signs of degeneration or 
apoptotic changes in both the sample so Cortex region showed normal neurons with 
polygonal to round cell bodies containing dense cytoplasm. 
HIGH DOSE: 
The appearance of Hippocampal neurons was normal with dense network  . 
No signs of ischemic changes in the cerebral hemisphere. 
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HISTOPATHOLOGY OF HEART 
        CONTROL        HIGH DOSE 
Low Power Magnification 10X          Low Power Magnification 10X
     
High Power Magnification 40X            High Power Magnification 40X   
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CONTROL : 
 Perfectly -arranged myocardial fibres, clear transverse striation and normal 
the structure was observed. 
 The appearance of cardiomyocyte was normal with a dark nuclear region. The 
nuclei of muscle fibres appear oval arrangement. 
HIGH DOSE : 
 Myocardial cells appear normal with well-defined mycoplasma and prominent 
nucleus and nucleolus. 
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HISTOPATHOLOGY OF LUNG 
 
 
CONTROL     HIGH DOSE 
 
Low Power Magnification 10X  Low Power Magnification 10X                        
   
High Power Magnification 40X    High Power Magnification 40X   
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CONTROL : 
 The bronchial opening appears regular with no signs of infiltration . 
 The appearance of the alveolar network was normal . 
 The nucleus of type I and II alveolar cells look normal.  
HIGH DOSE : 
 The perivascular region appears normal, Alveolar septa and wall appeared to    
widen  and normal. 
 No signs of lymphocyte cuffing. 
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HISTOPATHOLOGY OF STOMACH 
                   
                  CONTROL     HIGH DOSE 
Low Power Magnification 10X         Low Power Magnification 10X 
 
         
 
High Power Magnification 40X      High Power Magnification 40X 
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CONTROL : 
 Gastric glands, gastric glands including secretary sheath appears normal. 
 Normal gastric mucosa containing intact gastric gland cells, parietal cells which 
are a spherical cell with a deeply stained dark nucleus . 
HIGH DOSE : 
 No signs of an ulcer and glandular degeneration were observed.  
 The appearance of Sub-mucosa and gastric glands appear normal.  
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 HISTOPATHOLOGY OF LIVER 
CONTROL       HIGH DOSE 
Low Power Magnification 10X     Low Power Magnification 10X 
 
                     
  
High Power Magnification 40X    High Power Magnification 40X   
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CONTROL : 
 The rare appearance of Kupffer cells with no evidence of phagocytosis in 
intracytoplasmic region. 
 Liver parenchyma appears normal with no evidence of necrosis. 
 The appearance of terminal hepatic venules (central veins) in the portal tracts was 
normal. 
HIGH DOSE : 
 The apparent loss of liver parenchyma was observed.  
 Increase distant of liver sinusoids were observed. 
 The occasional presence of Kupffer cells with no evidence of phagocytosis in 
intracytoplasmic region. 
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HISTOPATHOLOGY OF KIDNEY 
CONTROL      HIGH DOSE 
Low Power Magnification 10X           Low Power Magnification 10X 
 
               
High Power Magnification 40X    High Power Magnification 40X   
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CONTROL : 
 Appearance of Podocytes and parietal epithelium in the glomeruli appears normal. 
 Proximal and distal convoluted tubule appears normal. 
 No signs of lesion or inflammation were observed. 
 No signs of cellular necrosis. 
HIGH DOSE : 
 Some renal tubules appear hypertrophic.  
 The appearance of Podocytes and parietal epithelium in the glomeruli appears 
normal. 
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HISTOPATHOLOGY OF SPLEEN 
CONTROL      HIGH DOSE 
Low Power Magnification 10X  Low Power Magnification 10X 
   
High Power Magnification 40X    High Power Magnification 40X   
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CONTROL : 
No signs of perivascular inflammation. 
The appearance of splenic sinuses, Splenic cord and endothelial orientation was  
Normal. 
The appearance of  LF– lymphoid follicle; PALS – periarterial lymphoid sheath 
was normal with no significant signs of enlargement. 
HIGH DOSE : 
 Marginal vascular zone radiated in between red and white pulp. 
 The appearance of splenic red pulp was normal . 
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HISTOPATHOLOGY OF TESTES 
CONTROL     HIGH DOSE 
Low Power Magnification 10X  Low Power Magnification 10X 
   
High Power Magnification 40X    High Power Magnification 40X   
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CONTROL : 
 Histo cytology of testicular tissue shows well-differentiated germ cells with  
respect of spermatogonia includes spermatid and sperm were observed. 
 The appearance of Leydig cells, interstitial tissue, seminiferous tubule, Sertoli 
cells and spermatogonia were normal. 
HIGH DOSE : 
 Histo cytology of testicular tissue shows well-differentiated germ cells with  
respect of spermatogonia includes spermatid and sperm were observed. 
 The appearance of Leydig cells, interstitial tissue, seminiferous tubule, Sertoli 
cells and spermatogonia were normal. 
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HISTOPATHOLOGY OF UTERUS 
CONTROL      HIGH DOSE  
Low Power Magnification 10X  Low Power Magnification 10X 
  
High Power Magnification 40X    High Power Magnification 40X   
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CONTROL: 
The appearance of endometrium, myometrium and uterine glands was 
normal. 
HIGH DOSE: 
  The appearance of endometrium, myometrium and uterine glands was normal 
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HISTOPATHOLOGY OF OVARY 
CONTROL     HIGH DOSE  
Low Power Magnification 10X  Low Power Magnification 10X 
   
High Power Magnification 40X    High Power Magnification 40X   
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CONTROL : 
 Histopathological analysis of ovary showing normal corpus luteum (CL) and 
Primordial follicles with few mature ovarian follicles with no signs of abnormality. 
HIGH DOSE: 
 The appearance of the antral follicle, primary oocyte and secondary follicles are 
normal. 
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6. DISCUSSION: 
I have selected Annabethi Chendhuram to evaluate its safety profile. After the 
preparation of the test drug Annabethi Chendhuram it underwent to the process of 
standardization for qualitative and quantitative analysis. The following analysis were 
done by using sophisticated instruments 
 Physicochemical analysis 
 Chemical Analysis 
 SEM 
 EDAX 
 FTIR 
 AAS 
 ICP-OES 
The safety profile was evaluated by Acute and Long-Term toxicity study on Wistar 
Albino rats as per WHO guidelines 
The Physicochemical analysis of ABC (Table:1) concluded that the following results 
 The loss on drying test is designed to measure the amount of water and volatile 
matters in a sample when the sample is dried under specified conditions. Moisture is one 
of the major factors responsible for the deterioration of the drugs and formulations. Low 
moisture content is always desirable for higher stability of drugs.
 
The percentage of loss 
on drying of ABC was 3.03% . Since the loss of drying of ABC is within the normal 
limit. So, the stability of the drug is higher. 
 The Ash limit Tests are designed to measure the amount of the residual. A high 
ash value is indicative of contamination, substitution, adulteration or carelessness in 
preparing the drug. The total Ash content and Acid Insoluble Ash values of ABC were 
68.68% and 58.47%. 
 
 Extraction value determines the number of active constituents in a given 
amount of the formulation when extracted with a solvent media such as water and 
alcohol. The water-soluble and alcohol soluble extract values provide an indication of 
the extent of polar and non-polar compounds respectively present in ABC. The extract 
values of Alcohol in ABC is 3.8% and water is 41.63%. From the above result, revealed 
that water is a little better solvent of extraction than alcohol. 
DISCUSSION 
 
105 
 
            Qualitative Analysis of Annabethi Chendhuram for Acid radicals, Basic 
radicals, and other constituents demonstrates the presence of  Iron, Sodium, Magnesium, 
Zinc, Aluminium, Lead, Phosphate, Carbonate and Alkaloids. In the Qualitative analysis 
iron is confirmly present in Annabethi chendhuram. So, the drug can be used in iron 
deficiency conditions clinically. 
 
  The INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROMETRY (ICP-OES) results showed that the Heavy metals like Lead,  
Mercury, Arsenic and Cadmium were found below detection level. Hence it may be safe 
for human consumption.  It also shows the presence of physiologically important 
minerals like calcium, iron, sodium, phosphate, magnesium, potassium, sulphur and 
phosphorus (Table-4). The presence of iron (221.32 mg/dl) in Annabethi chendhuram in 
large quantity is confirmed. So, the drug can be used in Iron deficiency conditions 
clinically. 
 HIGH RESONANCE SCANNING ELECTRON MICROSCOPY (HR-
SEM) Analysis of  Annabethi chendhuram by SEM revealed the size stabilization of 
particles on the process and presence of nano-sized particles. which is considerably less 
due to repeated calcination and grinding. Hence the drug may have increased 
bioavailability. The particles were spherical in shape with a smooth surface. The 
particles show the evenly distribution in the fields examined.  
 ATOMIC ABSORPTION SPECTROMETRY: Iron content of Annabethi 
chendhuram determined by AAS. The total iron content of the test drug has 31.26 ppm. 
Analysis of Annabethi Chendhuram by FOURIER TRANSFORM 
INFRARED SPECTROSCOPY (FTIR) revealed the Infrared absorption pattern of 
FeSo4 stretching was absorbed in the region of 493cm-1 to, 542cm-1. The sharp 
absorption peak observed in the region of 594 cm-1. The absorption peak at 3407 cm-1 
corresponds to O-H stretching which is bonded. The wide absorption peak at 1624 cm-1 
may be due to the vibrational intensity of C=C group. 
In Acute toxicity study, there were no abnormal signs reported at the dose level 
of 250 mg/kg/b.wt within 24hours in Wistar Albino Rats. No mortality and No gross 
pathological changes have been seen in the internal organs of both control and treated 
groups in the 14 days of study period and the Body weight, food intake and water intake 
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of animals were normal in both control and treated group animals. 
Long-term Toxicity Study was conducted for about 90 days as per WHO 
guideline in 3 doses low dose (25mg/kg b.wt), mid dose(125mg/kg b.wt), high dose 
(250mg/kg b.wt). Animals were observed throughout the period. The behaviour signs 
parameters there was no toxic signs were observed in all the control and treated 
groups.The body weight changes were significantly increased when compared to control 
group. Food intake and water intake changes were also significantly increased in high 
dose group when compared to control group. But they are within physiological limit, and 
this study reveals that it does not adversely effect the basic metabolic process of the 
experimental animals. After 90 days animals were sacrificed and blood samples were 
collected and investigated. In haematological parameters results revealed that there were 
decreased significant in MCV value in test group ( mid dose group ) animals when 
compared to control group. In biochemical parameters increased significant changes  in 
TGL in test groups (low dose) when compared to control group. The other 
haematological and biochemical parameters such as lipid profile, renal and hepatic 
parameters were normal in test groups when compared to control group. 
 The histopathological study on the organs such as brain, heart, lung, kidney, 
spleen, liver, stomach, uterus ,ovary and testes was normal in  high dose groups when 
compared to control. 
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7.SUMMARY 
Annabethi chendhuram is used for the treatment of Paandu (Anaemia), Suram 
(fever), Seetha bethi (Dysentry) as mentioned in the Siddha literature. The raw drugs 
were procured from a reputed shop in Chennai. The herbal and mineral drugs were 
identified and authenticated by Botanist and Dept. of Gunapadam HOD, National 
Institute of Siddha. The raw drugs were purified and the medicine was prepared as 
mentioned in the Siddha literature. On organoleptic examination, the finished product 
seems to be dark brown in colour. 
In a physicochemical analysis of Annabethi Chendhuram, loss on drying at105
o
C 
of 3.03%w/w. Total Ash value, Acid value, insoluble Ash value, Water, and Alcohol 
soluble Extractive values reveal the purity of the test drug. Qualitative Analysis of 
Annabethi Chendhuram demonstrates the presence of Iron, Sodium, Magnesium, Zinc, 
Aluminium, Lead, Phosphate, Carbonate, Alkaloids. 
The result of AAS confirms that Iron concentration in Annabethi Chendhuram. 
ICPOES results confirm Heavy metals like Lead,  Mercury, Arsenic and Cadmium were 
found below detection level. SEM result confirmed the presence of nano-sized, and 
spherically shaped particles with a smooth surface in even distribution. 
Analysis of Annabethi Chendhuram by Forier transform infrared spectroscopy 
(FTIR) revealed the Infrared absorption pattern of Feso4 stretching was absorbed in the 
region of 493cm-1 to, 542cm-1. The sharp absorption peak observed in the region of 594 
cm-1. The absorption peak at 3407 cm-1 corresponds to O-H stretching which is bonded. 
The wide absorption peak at 1624 cm-1 may be due to the vibrational intensity of C=C 
group. 
The toxicological evaluations  of Annabethi Chendhuram was conducted  as per 
WHO guidelines. In acute toxicity study, no signs of toxicity and mortality were 
observed throughout the study period up to the dose of 250 mg/kg/ b.wt. Thus, the LD50 
value of Annabethi Chendhuram was found to be greater than 250mg/kg/ b.w. 
In 90 days long term Toxicity Study, behaviour signs parameters there was no 
toxic signs were observed in all the control and treated groups. The body weight ,food 
intake, water intake significant changes were observerd in treated groups when 
compared to control group. In haematological parameters except (MCV), Lipid profile 
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except(TGL), Renal parameters, and Hepatic parameters was normal in treated groups 
when compared to control group. The histopathological study on the organs such as 
brain,heart, lung, liver, spleen, kidney, stomach, testes, and ovary was normal in high 
dose groups when compared to control group. 
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8.CONCLUSION 
The results of analytical studies of ANNABETHI CHENDHURAM (ABC) reveals the 
Purity and Bioavailability of the drug and thus it proves that ABC involves scientific and 
systematic detoxification process with enhanced therapeutic potential. The heavy metals 
were found to be below detection level. In vivo toxicity studies indicate that there was no 
mortality and signs of toxicity observed for the acute oral administration of ABC up to 250 
mg/Kg b.Wt. A single oral dose of 250mg/Kg b.Wt. was concluded as LD50 from the 
result. In long-term toxicity study, there were no abnormal significant changes in the 
biochemical parameter in ABC treated groups (Low,Mid and High dose) when compared 
to the control group. The histopathology report also confirms that there were no 
remarkable cellular changes at high dose level. Based on these results it can be concluded 
that the safer dose of Annabethi chendhram is 65 to 130 mg (BD/day)) for human 
consumption which is narrated in Gunapadam Thathu Jeeva Vaguppu. Thus ABC can be 
safely used in the management of Anaemia in pregnant women and children which is the 
current public health challenge our country is facing. In future, the research findings of the 
present study will be the first step in the evaluation of  chronic toxicity study,teratogenicity 
and genotoxicity study of ABC. 
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